Wantstats
IndustriesCompaniesCharts & Stats
Leads DBAdvisoryPricingContact us
Login
/Company Profiles

Deep Intelligence Across Industries

All CompaniesFortune 500Aerospace & Defense iconAerospace & DefenseAgricultureAutomotive iconAutomotiveFinancial Services iconFinancial ServicesChemicals & Materials iconChemicals & MaterialsConsumer Goods iconConsumer GoodsEnergy & Power iconEnergy & PowerEquipment & Machinery iconEquipment & MachineryFood & Beverages iconFood & BeveragesHealthcare & Pharma iconHealthcare & PharmaInformation Technology iconInformation TechnologyManufacturing & ConstructionMRO iconMROProfessional Services iconProfessional ServicesSemiconductors

Showing 14441 companies

AUK

AUK Corp.

Premium
Information Technology

AUK Corp. is a small-cap Korean maker of commodity discrete semiconductors and optoelectronic components. Its main lines are infrared photo sensors, photo interrupters and photocouplers, small-signal and power transistors, diodes and MOSFETs, and LED packages and chips. It is the Korean listed arm of the Japanese-founded Kodenshi group, controlled by founder Hirokazu Nakajima and related entities with 53.13%. Production is centred in Iksan, Jeollabuk-do, with in-house silicon and compound wafer fabs alongside packaging lines, and its customers are consumer-appliance, office-equipment, automotive and industrial makers. Revenue has fallen from KRW 177 bn (FY2017) to KRW 133 bn (FY2025), and operating margin has stayed within ±5% for a decade. The balance sheet is effectively debt-free, with about KRW 90 bn of cash and short-term investments against a ~KRW 404 bn ex-treasury market value. Since March 2026 the share price has traded mainly on a speculative "photonics/optical semiconductor" theme. The company told the exchange in August 2026 that it had nothing to disclose that would support that theme. --- **What the company does.** Per S&P Capital IQ's profile, which is drawn from company filings, AUK manufactures and sells electronic parts in Korea and abroad across three families: 1. **Opto sensors:** IR emitters, detectors, LEDs, IR receiver modules, infrared transceiver modules, photo interrupters, optical encoders, paper and UV sensors, distance sensors. 2. **Power semiconductor devices:** MOSFETs, bipolar transistors, diodes, power-management ICs, analog ICs, IGBTs, SiC power devices, modules and packages. 3. **LED and silicon photo chips,** plus a unit-process and wafer business that sells processing capacity and wafers. The stated application set is broad: monitors, audio, set-top boxes, cameras, phones and notebooks, refrigerators, air-conditioners, washing machines, robot cleaners, air and water purifiers, printers and copiers, ATMs and vending machines, medical equipment, LED lighting, conveyors, automotive, induction heating, industrial equipment and drones. **Revenue mix by product (FY2025, DART business report as reported by alphadistill).** Photo sensors 45.96%, transistors and other discrete semiconductors 36.34%, LEDs 15.63%, other about 2.07% by residual. In 1H2026 photo sensors rose to about 50.4% of revenue (about KRW 35.9 bn of KRW 71.3 bn). **Business model and revenue model.** Revenue is almost entirely product sales of components. Each line is a high-volume, low-ASP catalogue part sold through direct OEM accounts, group sales companies and distributors. There is no disclosed subscription, licensing or service revenue apart from the "unit process and wafer" foundry-type sales, which are not quantified separately. Pricing is per unit and negotiated. Pricing terms are not publicly disclosed. **Value-chain position.** AUK is vertically integrated, which is unusual at its size. The 2010 merger combined a silicon fab (legacy AUK), an optical-sensor and LED packager (Korea Kodenshi) and a compound-semiconductor fab (Naraygion). At the time the company said this made it the only Korean company apart from Samsung Electronics to own both silicon and compound fabs (News Tomato, June 2010). AUK also buys outside wafers. An investor write-up citing the raw-materials section of the business report lists DB HiTek and a supplier rendered in Korean as 프라우텍 as chip/wafer sources, and the report refers to using multi-project-wafer (MPW, external fab) services to obtain product characteristics. The practical model is a hybrid: in-house front-end for legacy discrete and LED chips, external foundry for some newer designs, and in-house back-end packaging and test. **Customer types and end-markets.** Customers are consumer-appliance OEMs, office-automation makers (printers, copiers, ATMs), automotive electronics suppliers and industrial-equipment makers. Named customer disclosures were not available from primary sources. Customer concentration is not publicly disclosed in sources reviewed. **Independent characterisation.** AUK is a mature, sub-scale catalogue-component maker. Its products — photo interrupters, photocouplers, small-signal transistors, through-hole and SMD LEDs — are commoditised, multi-sourced parts competing against Taiwanese, Chinese and Japanese suppliers. Gross margin of 10–17% over FY2021–FY2025 is well below scale peers (Everlight about 31% gross margin in FY2025, Vishay 19.4%). Operating income has been near zero since FY2023. Reported net income now depends heavily on interest income from its ~KRW 90 bn liquidity pool and on FX gains. The company does not make silicon-photonics, co-packaged optics, optical transceiver or high-speed photodetector products. None appear in the business report, and the company confirmed to KRX on 10 August 2026 that it had no matters subject to disclosure regarding the share-price surge. Its "optical semiconductor" exposure is to low-speed infrared sensing in appliances and office equipment, not data-centre optics.

Revenue$0.1B
Employees708
Market CapN/A
Founded1984
Iksan, South Korea

Unlock Verified Contacts

Access verified employee contacts

Decision-maker information to support your sales, lead generation, and business development. 5 users, 5,500 credits a month with rollover, and one credit per contact email.

USD650/mo
Buy Now

Powering the world's best teams.
From next-gen startups to established enterprises.

Google logo
Amazon logo
Microsoft logo
Intel logo
Neste logo
McKinsey & Company logo

What our clients say

Trusted by forward-thinking businesses
for data-driven intelligence

Noah Malgeri
Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
MR
Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Joseph Aguayo
Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
BL
Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.
Peter Groot Koerkamp
Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.
Younghwan Choi
Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
MI
Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
RK
Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
JL
Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
AM
Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Wantstats logo

Move faster. Think smarter. Win bigger.

Join our data driven community.

© 2026 All rights reserved by Wantstats Research and Media Pvt Ltd

footer vector

Pages

  • About
  • News
  • Charts & Stats
  • Contact
  • Ecosystem pricing
  • Privacy policy

Address

Wantstats Research and media Pvt. Ltd, Office No 104, Pentagon 4,
Magarpatta City, Pune - 411028,
Maharashtra, India.

Contact

support@wantstats.com

Follow Us

Follow Wantstats on FacebookFollow Wantstats on InstagramFollow Wantstats on LinkedInFollow Wantstats on YouTubeFollow Wantstats on WhatsApp
AU

AU Small Finance Bank Limited

Premium
Information Technology

| Field | Detail | |---|---| | Legal name | AU Small Finance Bank Limited | | Former name | AU Financiers (India) Limited. Renamed AU Small Finance Bank Limited on 13 April 2017 | | Founded / incorporated | 1996, Jaipur, Rajasthan, as a vehicle-finance NBFC (began operations as a vehicle-finance company in 1996 per published bank profiles) | | Incorporation jurisdiction | Republic of India (Companies Act). Regulated by the Reserve Bank of India (RBI) as a Scheduled Commercial Bank (Small Finance Bank licence) | | Headquarters | Jaipur, Rajasthan (registered office). Press releases are datelined Mumbai/Jaipur. New Delhi presence expanded with "AU Bank Capital House" (inaugurated 1 July 2026) | | Stock exchanges / tickers | National Stock Exchange of India: AUBANK. BSE: 540611 (equity). Additional BSE scrip codes exist for listed debt instruments: 974093, 974094, 974095, 974914, 974963, 975017, 975038, 976580 (per exchange filing dated 7 March 2026) | | Bloomberg | AUBANK IN | | ISIN | INE949L01017 (equity) | | CUSIP | Not applicable (no US listing or ADR programme) | | Face value | INR 10 per share | | Fiscal year end | 31 March | | Employees | Over 53,000 (June 2025, Basis Point Insight / company disclosures around the universal-bank approval). | | Customers | Over 125 lakh (12.5 million) at Q1 FY27 (Kotak Neo summary of Q1 FY27 press release). 120 lakh+ at Q2 FY26 (Q2 FY26 press release) | | Distribution | 2,626 touchpoints at Q2 FY26 (Q2 FY26 PR). Net 334 touchpoints added in FY26, including 78 liability branches. About 130 net touchpoints added in Q1 FY27 (Q1 FY27 PR). Over 1,000 microfinance branches serving 20 lakh+ customers across 59,000+ villages (press release, 29 September 2026) | | Statutory auditor | Joint Statutory Auditors (Q2 FY27 board-meeting intimation refers to "Joint Statutory Auditors"). | | Market capitalisation (current) | About INR 73,950 Cr at the NSE close of INR 987 on 1 October 2026 (derived: about 74.9 crore shares outstanding, implied by INR 77,715 Cr market cap at INR 1,037.25 on 17 September 2026 per Anand Rathi) | | Website | www.au.bank.in (legacy: www.aubank.in) | | Investor relations contact | investorrelations@aubank.in (per exchange filings) | | Company Secretary | Manmohan Parnami | AU Small Finance Bank is India's largest small finance bank. It is the first SFB to receive the RBI's in-principle approval (7 August 2025) to convert into a universal bank, and the first such approval for any lender in about a decade. The bank grew out of a three-decade-old Jaipur vehicle-finance NBFC. It is a secured, retail-led lender built around Wheels (vehicle) finance, MSME and secured business loans, commercial banking, housing and gold loans, and since the 2024 Fincare merger it also has a sizeable microfinance franchise. At September 2026 it held provisional deposits of about INR 1.70 lakh crore and a gross loan portfolio of about INR 1.54 lakh crore. Its NIM of about 5.9% sits well above universal-bank peers, while its 14–17% RoE trails the best private banks. The investment debate centres on three questions: - Can conversion to a universal bank narrow its deposit-cost gap? - Can it lift its CASA ratio above about 29%? - Can it hold high-yield growth without credit-cost relapses? --- ### What the company does AU Small Finance Bank is a full-service retail and commercial bank operating under a Small Finance Bank licence. Its core activities are: **Liabilities:** savings, current, term, NRI and premium-banking deposits. **Assets:** secured retail and commercial lending, with a smaller and deliberately contained unsecured book (microfinance, personal loans, credit cards). **Fee-based services:** distribution of insurance and investment products, foreign exchange and remittances (authorised dealer category-1 products), merchant acquiring, and card products. The bank's standard corporate description says it offers banking solutions across deposits, loans, credit cards, premium banking, remittance services, merchant solutions, insurance and investments (company "About" statement, reproduced in Chola Securities coverage of the August 2025 approval). ### The company's own characterisation Recent press releases describe AU as: - a Scheduled Commercial Bank and India's largest SFB since banking operations began in April 2017 (Sustainable Finance Framework press release, 2026); - holding "over three decades of experience in inclusive finance" (Sustainable Finance Framework document); - framing its long-term ambition as building a "Forever Bank" (Q4 FY26 press release, 27 April 2026). ### Independent characterisation AU is best understood as a high-yield, secured, self-employed-segment lender that has spent nine years building a deposit franchise to replace NBFC-era wholesale funding. Its competitive identity is underwriting the informal and semi-formal economy: small transport operators, tractor buyers, kirana and small-manufacturing MSMEs, and rural and semi-urban borrowers. The collateral is typically a vehicle, property or gold, and loan yields run about 13.7–14.1% on gross advances (Q1 FY27 PR). The structural weakness is funding cost. AU's cost of funds (6.48% in Q1 FY27) is materially above large private banks, because SFBs have historically had to pay a deposit-rate premium to attract depositors who see them as riskier. CEO Sanjay Agarwal has said explicitly that even as a universal bank AU will compete mainly with NBFCs rather than large banks (Outlook Business, August 2025). That remark is a useful lens: AU's universal-bank thesis is about cheaper liabilities funding its existing NBFC-style asset franchise, not a pivot into large-corporate banking. ### Business model and revenue model | Revenue line | Nature | Significance | |---|---|---| | Net Interest Income | Spread between loan/investment yields and cost of deposits/borrowings | Dominant. NII of INR 9,113 Cr in FY26 vs. other income of roughly INR 3,000 Cr (FY26 other income not fully verified; quarterly run-rate INR 724–811 Cr) | | Core fee income | Loan processing, deposit and transaction fees, cross-sell (insurance/MF), AD-1 forex, cards, merchant | Core other income INR 748 Cr in Q4 FY26 (+14% YoY) and INR 680 Cr in Q1 FY27 (+33% YoY) | | Treasury income | Gains on investment portfolio | Volatile: INR 300 Cr in Q1 FY26 (up about 1,479% YoY, Muthoot Securities), then minimal in Q1 FY27 when total other income fell 15% YoY | | PSL certificate sales | Monetisation of priority-sector surplus | Part of other income. Amount not separately verified | In the template's taxonomy, the revenue model is essentially 100% "service" (financial intermediation). There is no product-sale, subscription or licensing revenue. ### Value-chain position, customers and end-markets AU is a balance-sheet intermediary. It originates loans directly through its own branch, DSA and dealer network, holds them on balance sheet, and sometimes sells down through securitisation, direct assignment or IBPC (an inter-bank participation certificate, a way of sharing loan exposure with another bank). Off-book components were INR 3,480 Cr at September 2026 (provisional update). **Customer types:** - retail depositors, including NRIs and affluent "Royale" customers; - self-employed individuals and micro-entrepreneurs; - MSMEs; - vehicle buyers and transport operators (cars, commercial vehicles, tractors); - home-loan borrowers in affordable and mid-income segments; - gold-loan borrowers; - women's joint-liability groups (microfinance); - mid-market corporates, NBFCs and real-estate developers (commercial and institutional banking); - government and institutional depositors. **End-markets:** - Indian retail credit: vehicle finance, MSME, housing, gold, microfinance, personal loans, cards. - Indian retail deposits. - Commercial banking, including NBFC lending and agri-business.

RevenueN/A
Employees53,000
Market CapN/A
Founded1996
Jaipur, India
AtulAuto

Atul Auto Limited

Premium
Information Technology

Atul Auto Limited is a Gujarat-based, family-promoted manufacturer focused only on three-wheelers. It is one of the few Indian OEMs offering a full fuel spectrum: diesel, petrol, CNG, LPG and electric (both L3 low-speed and L5 high-speed). It covers passenger and cargo applications under the "Atul" brand. With roughly 4% of the domestic three-wheeler market, it is a distant challenger to Bajaj Auto, Piaggio, Mahindra and TVS. Its main franchise is in Gujarat and western India, and it has a growing export business. The group also runs a captive vehicle-finance NBFC, Khushbu Auto Finance, which is now wholly owned. In January 2026 it consolidated its electric L5 vehicle business into the listed parent. The company is in an operational reset: - FY26 consolidated revenue reached a record ₹824 crore. - Net profit roughly doubled. - An Exponent Energy rapid-charging EV contract adds a visible order pipeline. - Management is consolidating manufacturing at its Ahmedabad plant and will exit the original Rajkot site by December 2026. --- ### What the company does Atul Auto designs, manufactures and sells three-wheeled commercial vehicles (3Ws). These are auto-rickshaws for passengers and small goods carriers, sold under the Atul brand. The company also sells spare parts, components and allied products (CRISIL rationale, Jan 2026). The range covers: - **Passenger and cargo body types**, including pickups, high-deck vans, delivery vans and passenger carriers. **Several fuel types:** diesel, petrol, CNG, LPG and electric. The electric range covers both lithium-ion L3 e-rickshaws/e-carts and L5 electric autos (Business Standard/Capital Market company descriptor, May 2026; Wright Research brand list). The group runs two operating segments under Ind AS 108: 1. **Automobiles Business.** ICE and EV three-wheelers, spares, and since 15 January 2026 the L5 EV division absorbed from subsidiary Atul Greentech. 2. **Non-Banking Financial Business.** Retail vehicle financing through wholly owned subsidiary Khushbu Auto Finance Limited (KAFL), mainly for buyers of Atul vehicles (FY26 consolidated results, ScanX; PitchBook segment description). ### Company's own description Atul Auto's investor communications describe it as a leading Rajkot-based three-wheeler maker with a complete product range across diesel, petrol, CNG, LPG and electric. The Capital Market/Business Standard house descriptor, drawn from company releases, uses the same wording (Q4 FY26 results coverage, 16–18 May 2026). The CRISIL rationale summarises the business similarly: goods and passenger 3Ws under the Atul brand plus spares, components and allied products, with two plants in Rajkot and Ahmedabad. ### Revenue model | Revenue stream | Model | Approx. share of FY26 segment revenue | Basis | |---|---|---|---| | Vehicle sales (ICE + EV), domestic | Product sale to dealers (wholesale dispatch) | Majority of ₹779.19 cr Automobiles segment | FY26 segment disclosure | | Vehicle sales, export | Product sale to overseas distributors | Included in Automobiles. Rupee split not disclosed; ~14% of FY26 units (derived, §7) | Monthly sales filings | | Spare parts & allied products | Product sale through dealer network | Included in Automobiles. Not separately disclosed. | CRISIL | | Vehicle finance (interest & fees) | Lending / interest income via KAFL | ₹52.43 cr (6.3%) | FY26 segment disclosure | | Subscription / licensing | None disclosed | 0% | — | The model is overwhelmingly a product business (~94%) with a small but increasingly profitable captive-finance annuity (~6% of segment revenue and ~19% of segment profit in FY26). ### Value-chain position Atul Auto is a vertically integrated OEM. It does body/chassis fabrication, painting and assembly at its own plants. Engines and EV powertrain components are mostly sourced: Valeo 48V motor drives and Delta-Q chargers were named at the 2023 EV launch (PTI via TradeBrains). Under the Exponent contract, the battery system and powertrain come from Exponent and Atul acts as the contract OEM (NSE intimation, 24 Apr 2026). Downstream, it sells through a dealer network across India and through export distributors. The dealer network size was not disclosed in sources reviewed. One related party is the promoter-owned Khushbu Auto Pvt. Ltd., an authorised dealer for the Ahmedabad region with an FY27 related-party transaction limit of ₹120 crore (38th AGM notice, Aug 2026). The group also finances end-buyers through KAFL. ### Customer types and end-markets **Owner-drivers and small fleet operators:** in passenger transport: shared autos and last-mile commuter connectivity in tier-2/3 towns and peri-urban areas. **Micro and small businesses:** using cargo 3Ws. Disclosed applications include milk-can carriers, water-bottle carriers, bakery vans, edible-oil tin carriers, gas-cylinder carriers, appliance carriers, vegetable vans, pizza and ice-cream vans (Wright Research company description). **EV fleet operators and energy-as-a-service partners:** The Exponent contract targets passenger fleets needing 15-minute rapid charging. **Export markets:** Jio partnership communications cite South America, the EU and Eastern Africa as target regions (Business Standard/PTI, Oct 2024). ### Independent characterization Atul Auto is a niche, regionally concentrated challenger in a market dominated by Bajaj Auto. Its moat is a long-standing brand in Saurashtra and Gujarat, low-cost manufacturing, and an unusually broad fuel range for its size. CRISIL notes that a major share of revenue comes from Gujarat and a few other states. The main analytical tension is scale. Atul sold 38,440 units in FY26, about 4% of an 836,231-unit domestic wholesale market. Its EBITDA margins of roughly 10% sit structurally below Bajaj Auto's ~20%. Several FY26–FY27 decisions aim to fix operating leverage and the economics of the EV transition rather than to grow share outright: - Absorbing the L5 EV business. - Closing the Rajkot plant. - Taking OEM manufacturing work for Exponent.

Revenue$0.1B
Employees615
Market Cap$0.1B
Founded1970
Rajkot, India
Attacq

Attacq Limited

Premium
Information Technology

Attacq Limited is a Johannesburg- and A2X-listed South African REIT whose distinguishing feature is that it is both a precinct developer and a long-term owner. Its investment case rests on Waterfall City in Midrand, Gauteng. Waterfall City is a large leasehold mixed-use node anchored by Mall of Africa and surrounded by office ("collaboration") hubs, logistics hubs, hotels, residential towers and a data-centre campus. Attacq holds 70% of the vehicle that owns Waterfall City; the Government Employees Pension Fund holds the other 30%. Outside Waterfall City, Attacq owns dominant regional malls and mixed-use precincts in Pretoria, Potchefstroom, George and Stellenbosch. Since 2023 it has de-geared from about 37% to 25% loan-to-value, exited all non-South African holdings, and compounded distributable income per share by about 19% a year from FY2022 to FY2026. As a result, it is now a domestic, development-led growth REIT with a self-funded pipeline of land and development rights. --- ### Company's own description (paraphrased from FY2026 results) Attacq describes itself as a South African REIT listed on the JSE and A2X. Its stated purpose is creating places that put people first. It positions itself as an owner and precinct developer that builds destinations intended to generate sustainable growth and long-term value for stakeholders. The FY2026 results announcement organises the business around two "key business drivers": 1. **Waterfall City**, comprising the completed real estate portfolio, developments under construction and leasehold land. 2. **Rest of South Africa**, comprising the remainder of the completed South African portfolio. Until FY2025, a third driver, Other investments, captured non-core holdings. These were the Rest of Africa malls and, earlier, the MAS P.L.C. shareholding. That category has largely been retired following the FY2025 exchange of the Rest of Africa assets for a 4.47% stake in Lango Real Estate. The company organises the portfolio into four use-based sector "hubs" plus an "other" category: **Retail-experience hubs:** (shopping centres) **Collaboration hubs:** (offices) **Logistics hubs:** (warehousing, distribution and light industrial) **Hotels:** - Other (including the data-centre shell) Residential is developed for sale as sectional title through joint ventures and is carried as inventory, not investment property. ### Business model Attacq's model has three linked engines. **(a) Rental annuity.** Completed buildings generate contractual rental income. FY2025 escalations averaged a weighted 6.9%. Income also includes turnover rental, recoveries of municipal and diesel costs, and parking. In FY2025, rental income was about R2.9 billion against gross revenue of about R2.9 billion, so rental income is effectively the whole revenue line. **(b) Development pipeline.** Through Attacq Waterfall Investment Company Proprietary Limited (AWIC), Attacq holds notarial leasehold development rights over Waterfall City. These rights must be proclaimed by the end of 2040 under the AWIC leasehold agreement. As at 30 June 2025, the group held 1,109,103 m² of effective development rights. AWIC manages a total of 1,422,894 m² of bulk, including Sanlam's share of Waterfall City Junction. Developments are mostly retained as income-producing assets. Some are pre-let and client-led, while others are speculative, especially generic logistics boxes. Residential towers are built in joint ventures and sold. **(c) Fee and capital recycling.** Attacq earns third-party asset and property management fees, which the company cites as a contributor to FY2025 distributable income growth in the Rest of South Africa. It also earns development-management fees on joint ventures, profits on sectional-title sales (R1.1 million in FY2025; R7.3 million in FY2024) and land sales. One example is the conditional sale of the LP12 site to Balwin Properties. ### Revenue model mix | Revenue type | Character | Evidence | |---|---|---| | Contractual base rental | Recurring, escalating (weighted average 6.9% escalation, FY2025) | FY2025 directors' commentary | | Turnover rental (retail) | Variable; rises with tenant sales | Mall of Africa turnover rental grew 91.6% in FY2023 (BusinessTech) | | Municipal and diesel recoveries | Pass-through; municipal recovery ratio 97.8% in FY2026 | FY2026 results release | | Asset/property/development management fees | Fee income from joint ventures and co-owners | FY2025 commentary | | Sectional-title sales (residential) | Episodic, recognised on transfer | Ellipse Waterfall phases 1–3 | | Land and bulk sales | Episodic | LP12 conditional sale to Balwin | | Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | |---|---|---|---|---|---| | Rental income (ZAR M) | 2200 | — | 2500 | 2868.1 | 3039.5 | There is no subscription or licensing revenue. The product-versus-service distinction does not apply in the conventional sense: about 99% of revenue is property rental, a service/lease model. Sources: FY2022 per Engineering News, 13 September 2022 (rounded R2.2 billion). FY2024 per FY2025 directors' commentary (rounded R2.5 billion). FY2025 and FY2026 per S&P Capital IQ via MarketScreener ("sales" line). ### Value chain position Attacq operates across the full real-estate value chain within its precincts. It controls the land through the leasehold, the masterplanning (Urban Design Development Framework) and the bulk infrastructure, including roads, water, electricity and a fourth city entrance. It then develops buildings, often with partners, manages the assets and properties itself, and runs precinct services such as security, mobility hubs and utility monitoring through its Smart Utility Hub. This end-to-end control is the key differentiator from conventional South African REITs, which mostly acquire completed buildings. ### Customer types and end-markets | Customer group | Examples (as disclosed) | End-market | |---|---|---| | National and international retailers | Checkers/Shoprite (Checkers Hyper, Sixty60), Woolworths, Game, Mr Price, Decathlon, The North Face, True Religion, Benetton, Spur, PEP, PNA, Pick n Pay Clothing, Markham, KFC | SA consumer retail | | Corporate office occupiers | PwC, Cell C, Tiger Brands, Boogertman + Partners, Siemens Energy, Novozymes/Novonesis, Pragma, iOCO, Huge Group, Sinotile, PSG Wealth, Auditor-General of South Africa (Lynnwood Bridge) | Corporate and professional services, telecoms, FMCG, public sector | | Logistics and industrial occupiers | Cotton On, Plumblink, Amrod, Cummins, and an unnamed national client for a client-led distribution facility | Retail distribution, industrial, wholesale | | Digital infrastructure | Vantage Data Centers (JNB1 campus; JNB 12.1 under a 20-year lease) | Hyperscale and colocation data centres | | Hospitality | Two operating hotels in Waterfall City (operators not named in the sources reviewed); African Rain Collection for the planned conference centre and hotel | Business travel and MICE | | Residential buyers | Ellipse Waterfall and Aspire purchasers | Upper-middle-income urban residential | ### Independent characterisation Attacq is best characterised as a "precinct REIT with an embedded land bank." Its earnings quality is now that of a domestic diversified REIT: - High collections: 99.8% in FY2026. - Retail-heavy value base: 56% of FY2025 completed-portfolio value. - A weaker office book: collaboration-hub occupancy was 84.3% in Waterfall City at FY2025, with negative reversions of 18.7% in FY2025. Its growth algorithm is unusual. Because Attacq controls the land and infrastructure, it can deliver new GLA at development yields above acquisition yields without competing for stock in the open market. The GEPF transaction (2023) monetised 30% of this land bank at book-related value. That allowed Attacq to de-gear without issuing equity. The consequence is that 30% of Waterfall City's earnings and value now sit with minorities.

RevenueN/A
Employees168
Market CapN/A
Founded1997
Midrand, South Africa
ATS

ATS Corporation

Premium
Information Technology

ATS Corporation is one of the world's largest independent automation solutions providers. It designs, builds, commissions and services custom and repeatable automated manufacturing, assembly, test, processing and packaging systems for multinational customers in regulated, high-reliability markets. Life sciences is its largest vertical, accounting for 51% of FY2026 adjusted revenue. It is followed by consumer products and warehouse packaging, food and beverage (including global tomato-processing leadership through CFT), energy (notably CANDU nuclear refurbishment and small-modular-reactor programs) and a shrinking, now-repositioned transportation/EV business. FY2026 adjusted revenue was C$2.97 billion. Roughly one-third of revenue is reoccurring aftermarket, spares and repeat product revenue, which partly cushions the project cycle. ATS combines a decentralized, acquisition-built portfolio with a lean operating system, the ATS Business Model (ABM). Under a new CEO, it is resetting its cost base through an 18-month Fixed Cost Transformation Program aimed at a 15% adjusted operating margin. --- ### Company's own description (FY2026 / Q1 FY2027 disclosure) ATS describes itself as an industry-leading automation solutions provider to many of the world's most successful companies. It says it applies its knowledge base and global capabilities across custom automation, repeat automation, automation products, and value-added solutions including pre-automation and after-sales services. These capabilities address the manufacturing automation and service needs of multinational customers. In the Q1 FY2027 boilerplate the end-markets are listed as life sciences, food and beverage, industrial and consumer, and energy. Transportation was folded into "industrial & consumer" from Q1 FY2027. ### What ATS actually does — independent characterization ATS is best understood as a portfolio of engineered-equipment and systems-integration businesses run under a common operating system and capital-allocation framework. It operates at four layers of the industrial value chain: 1. **Pre-automation and engineering.** Concept design, simulation, process development, digital and MES integration (Process Automation Solutions, IPCOS, IT.ACA) and front-end engineering for nuclear and SMR programs. 2. **Custom integration and automation systems.** Turnkey, one-off or low-volume production lines. Examples include auto-injector and wearable-device assembly for pharma (GLP-1 programs), contact-lens lines, pre-filled syringe lines, EV battery-module assembly historically, and nuclear fuel-handling and refurbishment tooling. 3. **Products and equipment.** Standardized or modular machines and platforms, sold repeatedly. Examples are SuperTrak linear-motor conveyance, freeze-dryers and laboratory equipment (SP Industries), radiopharmaceutical isolators and hot cells (Comecer), tube fillers and cartoners (IWK), packaging machinery (Paxiom, NCC), tomato and fruit processing lines (CFT), optical sorters (Raytec Vision), and laboratory-animal water systems (Avidity Science). 4. **Services including spare parts.** Aftermarket parts, retrofits, upgrades, field service, digital and consulting services across a large installed base. Management is embedding services directly into operating units to capture lifecycle revenue. ### Revenue model mix | Revenue type (FY2026) | C$ M | % of total | |---|---|---| | Revenues from construction contracts (percentage-of-completion project revenue) | 1599.2 | 53.8 | | Services rendered | 723.9 | 24.4 | | Sale of goods | 647.0 | 21.8 | | Total | 2970.1 | 100.0 | | Offering (FY2026) | C$ M | % of total | |---|---|---| | Custom integration and automation systems | 1033.7 | 34.8 | | Products and equipment | 927.1 | 31.2 | | Services including spare parts | 1009.3 | 34.0 | | Total | 2970.1 | 100.0 | ATS discloses revenue on three overlapping bases. **By contract type (FY2026, adjusted revenue C$2,970.1M, source: Q4 FY2026 release)** **By offering (FY2026)** The mix has shifted meaningfully toward products and services. Custom integration was 46.9% of revenue in FY2024 (C$1,422.3M of C$3,032.9M) and is 34.8% in FY2026, while services including spares rose from 27.3% to 34.0%. Management guides that "reoccurring revenues" will be 25%–35% of trailing-twelve-month revenue. On the Q4 FY2026 call, management said reoccurring revenue was about one-third of FY2026 revenue. ATS has no meaningful subscription or licensing revenue line. Software revenue (MES, Illuminate-type data platforms, PA digital services) is embedded in services and custom integration. In Q1 FY2027 ATS took a C$7.1M impairment on deferred development assets in its "smaller software-focused businesses." ### Customer types and end-markets Customers are predominantly large multinationals: global pharmaceutical and medical-device companies, consumer-goods and e-commerce/warehouse operators, food and beverage processors, nuclear utilities and fuel fabricators, and automotive/EV OEMs and tier-1s, although this last group is being de-emphasized. The Q4 FY2026 release highlighted several large enterprise life-sciences programs with long performance periods. ATS flags customer-concentration risk in its AIF, and the FY2025 C$171.1M settlement with a single EV customer shows how a single program can swing results. FY2026 adjusted revenue by market: life sciences 51.2%, consumer products 18.6%, food and beverage 16.8%, energy 7.6%, transportation 5.7%. Entering FY2027, about 80% of backlog is in regulated markets (life sciences, energy, food and beverage), per the Q4 FY2026 call. ### Value-chain position and economics ATS sits between component and robot suppliers (servo, PLC, vision, robotics vendors) and end manufacturers. Its value-add is application engineering, integration risk-taking and validated-process know-how, especially for regulated GMP and nuclear environments. The economics are structurally mid-margin: - FY2026 gross margin was 28.6% (calculated from IFRS revenue less cost of revenues). - The adjusted operating margin (adjusted earnings from operations, "AEO") was 10.6%. - The adjusted EBITDA margin was 13.9%. These margins sit below proprietary-product automation peers but above pure integrators. Working-capital intensity is significant because contract assets and milestone billing create cash-flow volatility. Non-cash working capital was 22.4% of revenue at FY2025 and 12.1% at FY2026.

RevenueN/A
Employees7,000
Market Cap$1.7B
Founded1978
Cambridge, Canada
ATN

ATN International Limited

Premium
Information Technology

ATN International Limited is a Kolkata-based, NSE/BSE/CSE-listed company that began as a SEBI Category-I merchant banker in the mid-1990s. It managed public and rights issues, provided corporate advisory services and, at one stage, operated a 4.1 MW wind power plant in Tamil Nadu. Today it is a dormant-to-residual investment entity. Data aggregators describe it as engaged in investment in, or trading of, shares and securities in a single segment, operating only in India. Operating revenue was nil in FY2026 and has not exceeded INR 0.21 crore in any of the last five years. Other income keeps the company close to breakeven. Accumulated losses of INR 23.46 crore exceed paid-up capital of INR 15.78 crore, so net worth is negative (about INR −7.68 crore). Promoters own only 0.17%, and the stock has not traded since May 2022. The company was swept into SEBI's August 2017 shell-company surveillance action, which was later revoked. Its investment relevance today is limited to a possible corporate restructuring or reverse-merger use of the listed vehicle. --- The FY2024-25 Directors' Report (41st Annual Report), as reproduced by IIFL, states that there was no change in the nature of the company's business during FY2025. It does not elaborate further in the extract reviewed. MCA records classify the company's main line of business as financial intermediation, excluding insurance and pension funding. **Third-party descriptions (they differ):** The legacy profiles describe the company as it was in the 1990s. **Independent characterisation.** On the financial evidence, ATN International is a non-operating listed company: **Revenue model:** Operating revenue ("sales") was INR 0.00 crore in FY2026, INR 0.21 crore in FY2025, and INR 0.03–0.09 crore in FY2022–FY2024. Income now comes mainly from "other income" (INR 0.44 crore in FY2026). This is consistent with interest, gains or liability write-backs rather than a recurring business. The breakdown of other income is not publicly disclosed in the sources reviewed. **Product/service mix:** No identifiable products, subscriptions or licensing. Historically (1994 onward), service fees from merchant banking, plus power sales from the wind asset. **Value-chain position:** Not applicable in any operating sense. The company is best described as a listed shell with a small residual investment book (INR 0.56 crore of investments at 31 March 2026) and fixed assets of INR 0.38 crore. **Customer types and end-markets:** Not publicly disclosed. Historically, corporate issuers raising capital in Indian primary markets. **Cost base:** Annual expenses of about INR 0.4–0.7 crore cover listing fees, compliance, staff (five employees) and administration. The FY2025 Directors' Report states that no remuneration was paid to directors in FY2025.

RevenueN/A
Employees5
Market CapN/A
Founded1983
Kolkata, India
Atlas

Atlas Cycles (Haryana) Limited

Premium
Information Technology

Atlas Cycles (Haryana) Limited is one of India's oldest bicycle brands, founded in a tin shed in Sonepat in 1951 and, at its peak, ranked as India's largest (1965) and later second-largest cycle maker, with combined capacity of about 3.1 million cycles a year and exports to roughly 50 countries. Today the company is a shadow of that franchise: plant closures in 2014–2015 (Malanpur, Bawal), 2018 (Sonepat) and June 2020 (Sahibabad) reduced revenue from about INR 684 crore in FY2017 to INR 6.90 crore in FY2026. The listed entity is now best understood as a legacy brand and land-bank holding company with residual bicycle sales, whose balance sheet (net worth INR 379.5 crore, largely property, plant and equipment of INR 423 crore) dwarfs its INR 58.5 crore market value. Its investment case turns almost entirely on monetisation of a 20-acre Sonepat land parcel under a pending INR 60 crore sale, and on whether management can credibly revive bicycle operations. --- ### Company's own description In its FY2025 Management Discussion & Analysis (74th Annual Report), the company describes itself as a listed public company present in the bicycle segment for more than 70 years, with a brand it says is well accepted in India and internationally. Management states that it has widened its product range and is concentrating on "fancy" cycles to meet the changing preferences of younger buyers, arguing that rising middle-class incomes will make the fancy and kids' segments grow faster than traditional roadster cycles, with features such as disc brakes, suspension, alloy wheels and gears driving demand in metro and mini-metro cities. The FY2026 annual report summary (as reproduced by aggregators) states that the company sold bicycles worth about INR 690 lakh during FY2026 and is in the process of business revival during 2026. The company reports a single business segment, described in its iXBRL filing for FY2026 as "Cycles". ### Independent characterisation Atlas Cycles today is not a functioning mass-manufacturing business in the sense of its history. Key observations: **Scale collapse:** Revenue from operations fell from INR 684.28 crore (FY2017) and INR 649.87 crore (FY2018) to INR 155.90 crore (FY2020, the year in which Sahibabad was closed), INR 17.30 crore (FY2021), and between INR 1.73 crore and INR 17.14 crore in each year since. FY2026 revenue was INR 6.90 crore; Q1 FY2027 revenue was INR 1.54 crore. **Cost structure inverted:** Total expenses (INR 13.65 crore in FY2026) are roughly double revenue, yielding a negative operating margin of about 98% in FY2026 and negative 96% in Q1 FY2027. **Profits only from non-operating items:** The two profitable years since FY2020 — FY2024 (net profit INR 0.54 crore) and FY2025 (INR 9.51 crore) — were driven by other income/asset sale gains (INR 49.50 crore and INR 11.57 crore respectively), not by the bicycle business. **Asset-heavy balance sheet:** Property, plant and equipment of INR 423.00 crore (FY2026) accounts for about 88% of total assets of INR 482.64 crore. **Real-estate monetisation as the core near-term "business":** The company's most material corporate activity over the last 24 months has been the attempted sale of approximately 20 acres of land and buildings at its Sonepat unit for INR 60 crore. ### Business and revenue model | Dimension | Characterisation | |---|---| | Revenue model | Product sales (bicycles and components); 100% product-based. No service, subscription or licensing revenue disclosed | | Brand | Atlas (single master brand) | | Product mix (FY2024 annual report, by volume) | about 55% roadsters, 25% fancy, 20% kids' bicycles | | Value chain position | Historically vertically integrated (own steel tube plant at Gurgaon/Bawal, component manufacture, assembly). Current degree of integration not publicly disclosed; the tube plant was closed in FY2015 | | Customer types | Dealers/distributors serving retail consumers; historically institutional buyers (e.g. state government schemes for schoolchildren) and export distributors. Current customer concentration not publicly disclosed | | End-markets | Domestic Indian utility/commuter (roadster) market, youth/"fancy" market, kids' market; historically exports | | Working capital profile | Extremely stretched: debtor days 168 and payable days about 2,565 in FY2026 (Screener), indicating very slow customer collections and very long-unpaid trade creditors |

Revenue$0.0B
Employees14
Market CapN/A
Founded1950
Sonepat, India
Atishay

Atishay Limited

Premium
Information Technology

Atishay Limited is a Bhopal-based micro-cap that sells technology-enabled services to Indian state and central government agencies, public-sector undertakings and cooperative banks. Its core franchise is "last-mile" e-governance execution. This covers large-scale record digitisation and document management, electoral-roll database preparation and voter-ID printing, Ayushman Bharat (AB-PMJAY) PVC card printing and delivery, Census logistics kits, and PACS (Primary Agricultural Credit Society) computerisation. Alongside this, the company runs a retail fintech and assisted-services layer: the Zapurse platform, Rajasthan's e-Mitra kiosk network and micro-ATM deployments. In FY2026 it reported ₹55.77 Cr revenue and ₹7.14 Cr net profit. E-Governance contributed about 82% of revenue and almost all segment profit. The company is promoter-controlled (74.65%), lowly leveraged and order-driven. It is now trying to add proprietary AI products and its first export contract (Myanmar) to a lumpy, tender-based services base. --- ### What the company does Atishay is an IT-enabled services contractor to government. Its revenue comes from executing discrete government work orders and rate contracts won through competitive tenders and empanelments. Revenue from its own software products is a smaller share. The company's filings describe the business as information technology, database management, software development, e-governance and (retail) fintech services (source: Business Standard/Capital Market company line, FY2025–FY2026 result releases). The company website positions it as bridging the gap between citizens and public services, citing over 30 years of experience and a client base dominated by government and PSU entities (source: atishay.com, accessed Oct 2026). Screener's summary of the FY2026 Annual Report describes the company as a technology-driven IT services provider focused on India's digital transformation. It lists five domains: e-governance, financial inclusion, healthcare, electoral management and AI-enabled digital infrastructure. Offerings span customised software development, digitisation, large-scale data entry and scanning, document conversion, database management and doorstep delivery solutions. The summary also lists empanelments with TCIL, GIL, CEL and RailTel. ### Reporting segments (as defined by the company) According to data-vendor summaries of the segment note (MarketScreener), the company reports two segments: 1. **E-Governance (B2G):** preparation of electoral rolls and electors' photo identity cards, software development, and other business-to-government services for government departments and PSUs. 2. **Retail & Other Services (B2B/B2C):** multi-recharge and retail fintech services (Zapurse, e-Mitra transactions), software development and other B2B services. ### Business and revenue model | Revenue stream | Model | Nature | Indicative examples (filings) | |---|---|---|---| | Project/work-order services | Fixed-price work orders, usually GST-inclusive, with defined completion windows (25 days to 12 months) | Non-recurring, lumpy | Bihar registration-record digitisation ₹3.77 Cr / 180 days (Jan 2026); MP Census kits ₹5.49 Cr / 25 days (Mar 2026); West Bengal AB-PMJAY cards ₹11.16 Cr / 9 months (Jun 2026) | | Rate contracts | Multi-year panels where value depends on actual orders placed | Semi-recurring, volume-dependent | SEC Karnataka 5-year electoral database & roll printing (valid to 20 Jul 2030); SEC Karnataka SVIC printing (to May 2027) | | Revenue-share / transaction model | Share of fees per citizen-service transaction | Recurring, volume-driven | e-Mitra Local Service Provider (LSP), Ajmer/Bikaner/Jaipur divisions, 5 years — revenue accrues per transaction processed (LoA, 25 Nov 2025) | | Hardware supply + installation + AMC | Device supply (micro-ATMs, Wi-Fi/network) with maintenance | Part one-time, part annuity | Micro-ATM orders from Rajasthan central cooperative banks (Jul–Aug 2026); BSNL IIFM Wi-Fi + AMC ₹47.06 lakh (Jul 2026) | | Software development (domestic and export) | Development fee plus annual maintenance | Project plus annuity | Myanmar AI diagnostic platform: USD 295,740 Phase I + USD 80,000 p.a. maintenance (Jul 2026) | | Platform/fintech | Commissions on AePS, DMT, micro-ATM, BBPS, FASTag and recharge via an agent network | Recurring, transaction-driven | Zapurse (≈10,500 agents/outlets, ≈46 lakh customer base per a Trade Brains report on Q2 FY2026) | | Hospitality (legacy diversification) | Room/F&B revenue from Hotel Atishay, Bhopal (opened 2016) | Recurring | Current segment allocation and revenue not separately disclosed in accessed sources | **Product vs. service vs. subscription mix:** The company does not disclose a formal split. On the evidence of segment and order data, the business is overwhelmingly services and project-based (estimated at well over 80% of revenue in FY2026, given E-Governance at 81.9%). Recurring platform and subscription-like income — Zapurse commissions, e-Mitra revenue share and AMCs — is a minority. This characterisation is an analyst inference, not a company disclosure. ### Value-chain position Atishay sits at the implementation and last-mile execution layer of India's digital public infrastructure. It is usually a tier-2 or tier-3 contractor (state-level empanelled agency, Local Service Provider, or System Integrator under BSNL's MP circle). It is not a platform owner such as NIC, UIDAI or NPCI, nor a national prime SI. Its competitive edge is low-cost execution capacity: manpower for scanning and data entry, district-level logistics, and printing and delivery. It holds state empanelments and has a 25-year record with government buyers. The company has started to move up the stack with proprietary software (eSahyog, TrackVec, Maxidoo, AI modules), but these remain small relative to execution services. ### Customer types and end-markets | Customer type | Examples from filings (FY2024–FY2027 YTD) | |---|---| | State election commissions | SEC Karnataka (two rate contracts, consortium with Gundal Business Pvt Ltd) | | State health agencies (AB-PMJAY) | National Health Authority empanelment (Mar 2024); SHAS Maharashtra; Odisha; Haryana; Chhattisgarh (State Nodal Agency, DHS); West Bengal (Swasthya Bhavan) | | Revenue/registration departments | Dept. of Prohibition, Excise & Registration, Bihar; Municipal Corporation Ludhiana; PUDA, Punjab | | Census | Directorate of Census Operations, Madhya Pradesh | | Cooperative sector | Registrar of Cooperative Societies, Himachal Pradesh (PACS computerisation); MP Apex Bank/NABARD PACS project (2023); Rajasthan district central cooperative banks (Hanumangarh, Bikaner, Udaipur, Nagaur, Alwar, Jaipur, Barmer) | | State IT agencies | RajCOMP Info Services Ltd (RISL), Rajasthan; CHiPS, Chhattisgarh | | Central PSUs | BSNL (MP circle SI; IIFM Bhopal network); Central Electronics Ltd (CEL); RailTel; TCIL; GIL | | Education departments | Technical Education Dept., Himachal Pradesh (smart classrooms); Bihar ICT labs and smart classrooms | | International private | Global Top Link Technologies Company Ltd, Myanmar (AI diagnostics) | | Retail/micro-merchants | Zapurse agents and e-Mitra kiosk operators | **Independent characterisation.** Atishay is a state-government execution contractor with a fintech-distribution side business. Its earnings depend on the tender calendar: electoral cycles, AB-PMJAY card drives, the Census 2027 build-up and state digitisation budgets. Margins depend on project mix. Data-processing and digitisation work carries high margins, while hardware pass-through such as micro-ATMs and printing consumables carries thin ones. The Q1 FY2027 margin collapse shows how sensitive reported profitability is to this mix.

Revenue$0.0B
Employees285
Market CapN/A
Founded1989
Bhopal, India
Athos

Athos Immobilien AG

Premium
Information Technology

ATHOS Immobilien AG is a micro-cap Austrian residential landlord and project investor focused on affordable rental housing in the central Upper Austria region around Linz and Wels, with a small Vienna exposure. As of mid-2026 it owned 43 properties with about 63,200 m² of lettable space, 74% of it residential (733 flats), plus offices, retail, gastronomy and one retail park. In FY2025 it generated EUR 9.0m in revenue, of which EUR 6.69m was net rent. The business has three parts: long-term letting, opportunistic acquisition of apartment packages from developers, and an in-house brokerage desk created in 2019. Its stated motto is "stability before risk". The balance sheet is conservatively stated at historical cost: book value of property is EUR 108.3m against EUR 148.6m of total investment cost. Management's own valuation assumption, at a 3.6% yield, is EUR 186.1m. At the current share price the market value is well below these asset values. The trade-off is very thin reported earnings, because higher interest costs absorb most operating profit. --- ### What the company does ATHOS earns money in three ways. 1. **Rental and property management (core).** The company leases residential, office, retail and gastronomy units it owns, mostly in Linz, Wels, Enns, Steyr, Pregarten, Vöcklabruck, Gallneukirchen, Kirchschlag and St. Florian (Upper Austria), plus two Vienna assets. In FY2025, net rents were EUR 6.693m (74% of revenue) and recharged operating costs (Betriebskosten, BK) were EUR 2.220m (25%) [CP0726]. 2. **Project development and acquisition.** The company buys blocks of new-build apartments from third-party developers before completion and holds them as rental stock. Examples are Wohnpark GALLI in Gallneukirchen and PANO in Kirchschlag, both bought from Real Treuhand. It also carries out general refurbishments and attic conversions of existing buildings, such as Franz-Fritsch-Straße 6-8 in Wels and Landgutstraße 9 in Linz [AR2023], [CP0726]. 3. **Brokerage (Maklerbüro).** This desk was set up in 2019. It lets the company's own units (164 lettings in FY2025 vs 145 in FY2024) and takes third-party mandates for sale, letting and valuation. External commission revenue was EUR 93k in FY2025 (1% of revenue) [AR2025], [CP0726]. A fourth, non-recurring source of value is capital recycling. The company sells individual flats and, historically, larger commercial assets (retail parks Tumeltsham in 2020 and Wels-West in 2021). Gains are booked under "other operating income from disposal of fixed assets": EUR 0.69m in FY2025, EUR 6.49m in FY2020 [AR2025], [AR2021]. ### Revenue model mix (FY2025) | Revenue type | EUR k | % of revenue | Nature | |---|---|---|---| | Net rents | 6693 | 74.3 | Recurring, contractual (indexed leases) | | Operating-cost recharges | 2220 | 24.7 | Pass-through, matched by cost | | Brokerage commissions | 93 | 1.0 | Transactional service | | Revenue total | 9006 | 100.0 | — | | Gains on property disposals (other income, below revenue) | 692 | — | Non-recurring, opportunistic | Source: [CP0726], [AR2025]. There is no product, subscription or licensing revenue. ### Value-chain position and customers ATHOS sits at the owner/investor stage of the residential value chain. It does not build itself. It buys finished or near-finished units from developers (often Real Treuhand, the real-estate arm of the Raiffeisen group in Upper Austria), refurbishes ageing stock, and operates assets through an in-house team with external property managers. Customers are private households (flats), small businesses and professional practices (offices), local retailers and a supermarket (the presentation references a Spar construction-cost subsidy in Pregarten in 2024), and gastronomy operators [CP0726]. Lease mix is shifting toward fixed-term contracts. Between Feb 2025 and Jun 2026, open-ended residential tenancies fell from 423 to 343 and fixed-term tenancies rose from 290 to 375 [CP0726]. ### Company's own description (paraphrased from the 2026 presentation and IR page) ATHOS describes itself as a company that has focused for more than 35 years on affordable housing in central Upper Austria. Development and letting are its core competences, and the brokerage arm added in 2019 has become an essential pillar. It emphasises solid equity, qualitative over quantitative growth, a high share of let residential property, and investment only in regions it knows [IR], [CP0726]. ### Independent characterisation Economically, ATHOS is a small, regionally concentrated, historic-cost residential landlord with a hidden-reserve thesis. Its UGB accounts depreciate buildings, including degressive depreciation since 2023, rather than marking them to market. Reported earnings therefore understate economic returns, and book equity (EUR 48.7m) understates net asset value. The 2022–2025 period exposed the model's sensitivity to financing costs. Interest expense rose from EUR 0.11m (FY2021) to EUR 2.44m (FY2024). Over the same period the company funded roughly EUR 30m of acquisitions with bank debt, so net debt doubled from EUR 29.9m to EUR 62.7m. Pre-tax profit compressed to EUR 0.26m in FY2025 even as revenue reached a record [AR2021], [AR2025]. The equity story has since moved from growth to capital return: dividends kept at EUR 0.80, a 6% tender-offer buyback at EUR 47 in 2026, and selective flat sales to deleverage.

Revenue$0.0B
Employees6
Market CapN/A
Founded1989
Linz, Austria
Athena

Athena Global Technologies Limited

Premium
Information Technology

Athena Global Technologies is a Hyderabad-based micro-cap that began in 1991 as a software services and IT-education firm (VJIL Consulting) and now operates three disclosed reporting segments: offshore software services (application development, QA/testing, digital transformation, delivered mainly to US clients through its Schaumburg branch and a US subsidiary); real estate, which now drives the balance sheet; and online education through wholly owned subsidiary Tutoroot. The real estate asset is a 5-acre IT/SEZ development at Manikonda (Financial District) built under a joint development agreement with Phoenix Tech Zone. Healthcare-platform activity (MedleyMed) was restructured in March 2026. Economically, the company is now best understood as a promoter-controlled holding of a commercial real estate asset with a sub-scale software business attached. FY2024 included a ₹235.94 Cr non-cash fair-value gain on that property. Operating losses have persisted since FY2022, and debt has grown. The investment case depends on whether the property can be monetised through leasing or sale, starting with the 1,19,526 sq ft lease disclosed in September 2026. --- ### Company's own description (FY2023-24 Annual Report, MD&A — paraphrased) The company describes itself as a global provider of software application development, digital transformation, and QA & testing services to enterprises. The MD&A lists capabilities in: - AI services, such as real-time customer interaction and predictive/diagnostic applications - Blockchain solutions (described elsewhere by the company as built on Ethereum and Hyperledger) - Data science - IoT-based engagement solutions - Robotic process automation (RPA), chatbots and voicebots - Application development and product engineering - Production-environment support and QA The MD&A also states a focus on enterprise information management, enterprise integration and data warehousing services. Client sectors named are financial services, healthcare, oil, pharmaceuticals, retail, business services, education, IT and government. The FY2023-24 AR states that the company reports five segments on a consolidated basis: 1. Software services 2. Real estate 3. Online pharmacy platform services 4. Online trade of pharmaceutical products 5. Online education services The S&P/Simply Wall St description adds several service lines: - Digitalisation of records and OCR technology - Governance, risk and compliance (GRC) consulting - Voice and non-voice technical support - Business process optimisation - Advisory, structuring and sustainability consulting Screener's summary (citing the FY2022-23 AR) describes the business as software development and consulting, real estate activities, and IT-enabled business support services. ### Business model and revenue model | Dimension | Characterisation | Evidence | |---|---|---| | Software services | Mostly time-and-material and project-based offshore/onsite services; mainly export | FX earnings were ₹817.70 lakh in FY2024 against standalone revenue of ₹970.95 lakh (about 84% export) — FY2023-24 AR | | Real estate | Investment property held at fair value under Ind AS 40; income from leasing / sale of built-up space | FY2024 investment property recognised at fair value of ₹23,900 lakh — FY2023-24 AR; lease of 1,19,526 sq ft at ₹11.19 Cr/yr from 27 Nov 2026 — BSE Reg. 30 filing, 18 Sep 2026 | | Online education (Tutoroot) | B2C live online tutoring (subscription / course fees) for K-12 and competitive exams | Tutoroot launch coverage | | Healthcare platforms (MedleyMed) | B2B pharmacy aggregation and ERP SaaS, e-pharmacy trading, and telemedicine SaaS | Business India feature; FY2023-24 AR | | Mix | Product/licensing: negligible or not disclosed. Services: dominant in operating revenue. Subscription: small (education, SaaS). Real estate rental: expected to become dominant from FY2027 if the new lease commences. | Derived from the above | ### Value-chain position, customers and end-markets **Software services:** The company acts as a small offshore delivery vendor. It sits at the bottom of the IT services value chain, as a subcontractor or niche vendor to mid-sized US enterprises. It has no disclosed platform IP of scale. Named clients are not publicly disclosed. **Real estate:** The company is a land-owner and co-developer through a joint development agreement (JDA), where the developer builds and the parties share the built-up area. Its customers are office occupiers in Hyderabad's Financial District, which is a global capability centre (GCC) corridor. **Education:** Customers are students and parents in India (CBSE, ICSE, IGCSE, IB curricula and IIT-JEE/NEET preparation) and, aspirationally, global markets. **Healthcare (historic):** Customers were independent retail pharmacies (India has 8 lakh+ standalone medical stores, per Business India), stockists, virtual care providers, and US pharmacy businesses. ### Independent characterisation On the evidence, Athena Global is no longer primarily an IT services company. The key facts are: - Consolidated operating revenue has fallen from about ₹26 Cr in FY2020–21 to ₹11.2 Cr in FY2026. - Consolidated operating losses were recorded in each of FY2022–FY2026. - About ₹200–280 Cr of balance-sheet value sits in investment property. The company's value, its debt service and its equity story now all depend on the Manikonda property. The software business is too small to cover finance costs, which were ₹17 Cr in FY2026 (Screener) against operating revenue of ₹11.2 Cr. The healthcare and ed-tech subsidiaries have been loss-making or marginal capital sinks: the investment in Medley carried at ₹3,360.94 lakh (FY2021-22 AR) was ultimately sold for ₹125.34 lakh in March 2026. Investors should analyse Athena as a leveraged real estate holding company with an option on a small tech services business, not as an IT services compounder.

Revenue$0.0B
Employees65
Market CapN/A
Founded1991
Hyderabad, India
Atenor

Atenor SA

Premium
Information Technology

| Field | Detail | Source | |---|---|---| | Legal name | Atenor SA (société anonyme under Belgian law) | FY2025 Annual Report | | Former names | Atenor Group SA (used in annual reports to at least 2014); historically "Cominière" (name of the company when the current CEO joined in 1990) | Annual Report 2014 governance annex; FY2025 Annual Report (CEO biography) | | Founding year | 1910, per market-data providers (FMP, Craft, CB Insights). The company itself cites more than 30 years of real-estate development experience | Aggregators; atenor.eu/about | | Incorporation jurisdiction | Belgium; Enterprise no. BE 0403.209.303; RPM Brabant wallon | Press releases 2025–2026 | | Headquarters | Avenue Reine Astrid 92, B-1310 La Hulpe, Belgium (Nysdam building, owned by the group as investment property) | atenor.eu; FY2025 Results PR, Note 9 | | Primary listing | Euronext Brussels, continuous market, Compartment B, ticker ATEB | FY2025 Annual Report | | Secondary trading | Frankfurt/Düsseldorf (Z5S), London OTC (0NG6.L) — unsponsored lines | Parqet/Yahoo data | | ISIN / CUSIP | ISIN BE0003837540. CUSIP: not applicable (no US listing) | FY2025 Annual Report | | Shares outstanding | 61,029,780 (denominator since 10 Mar 2025); 313,427 treasury shares held by subsidiaries | H1 2026 Report | | Fiscal year end | 31 December | Annual reports | | Statutory auditor | BDO Réviseurs d'Entreprises SRL (represented by Christophe Pelzer) signed the H1 2026 review. EY Réviseurs d'Entreprises was auditor for FY2022. | H1 2026 Report; FY2022 Results PR | | Employees | 95 staff members (FY2025 Annual Report, "Atenor at a glance"); "around 100" (careers page); 104–111 per third-party aggregators | FY2025 AR; atenor.eu/people; Yahoo/MarketScreener | | Market capitalisation | ≈ €61M at €1.00 per share (13 Oct 2026); MarketScreener shows €1.02 on 14 Oct 2026 | ideal-investisseur.fr; MarketScreener | | Website | www.atenor.eu | — | The entity profiled is the listed company matching the identification details supplied: Atenor SA, listed on Euronext Brussels under ticker ATEB (Reuters/Yahoo-style code ATEB.BR), ISIN BE0003837540, headquartered in La Hulpe, Belgium. The supplied website (www.atenor.be) is a legacy domain. The company now publishes on www.atenor.eu, although its IR mailbox still uses the atenor.be domain. No change of listing venue has occurred. | Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |---|---|---|---|---|---| | Personnel costs (EUR M) | 4.78 | 5.43 | 5.60 | 6.02 | 5.48 | The company does not publish a consistent multi-year FTE series. Personnel costs are the best disclosed proxy. Sources: FY2022 Results PR (FY2021–22); FY2023 Results PR; FY2025 Results PR, Note 6 (FY2024–25). H1 2026 personnel costs were €2.32M, down 10% year on year [H1 2026 Report, Note 6]. Atenor is a mid-sized, Brussels-rooted urban real-estate developer that buys obsolete buildings and brownfield sites in European cities, permits and builds mixed-use schemes, and sells them to investors, occupiers and households. Its model is pure development-for-sale: it holds no long-term rental portfolio beyond its own head-office building. The company built its reputation on large Brussels office schemes and later expanded to ten countries. That expansion left it heavily exposed to office markets in Central Europe just as interest rates reset in 2022. Three years of losses (cumulative group-share loss of €285M over FY2023–FY2025), two dilutive equity raises and an eightfold increase in share count followed. Atenor is now mid-way through a 2025–2027 turnaround plan. The plan exits Central European offices, tilts the pipeline to residential (62% of m²), selectively builds pre-let or pre-sold Western European offices, and replaces bond funding with project-level bank debt. It is backed by a concert of Belgian family holding companies controlling 50.4% of the capital. --- ### Company's own description In its FY2025 Annual Report and press releases, Atenor presents itself as a leading, sustainability-focused real-estate developer listed on Euronext Brussels. It describes its specialism as mixed-use projects combining offices, housing, retail and public amenities, designed around "urban resilience". It credits its in-house research and development department, Archilab, with guiding each project from inception. The company frames its activity as a complete value-creation cycle that turns obsolete buildings and brownfields into dynamic urban spaces [FY2025 Results PR, "About Atenor"; FY2025 Annual Report, ch. 2]. The Annual Report's mission statement rests on four components [FY2025 Annual Report, ch. 4]: **Developer:** acquiring land, brownfields and obsolete buildings, then designing, building or renovating them. **Urban:** the city as the field of action. **Sustainable:** anticipating evolving environmental frameworks. **International:** dynamic markets served by local teams, with geographic diversification presented as a pillar of resilience. ### Independent characterisation Atenor is a merchant developer operating with a single reportable activity: property development of office and residential buildings, with retail treated as ancillary [FY2023 Results PR, Note 4]. Its economics are lumpy and project-driven: **Revenue model:** Effectively 100% "product" revenue from asset or unit sales, with small ancillary flows: - Turnover from sales of assets: €147.0M in FY2025. - Rental income on buildings held pending sale: €7.8M in FY2025 [FY2025 Results PR, Note 6]. - Project-management fees: €1.5M in H1 2026 [H1 2026 Report, Note 6]. - There is no subscription or licensing revenue. **Transaction structures:** Sales take several forms: - (a) asset deals; - (b) share deals (sale of the project SPV), recorded as gains or losses on disposal of investments under IFRS and therefore excluded from "turnover"; - (c) forward-funding or forward-sale contracts (VEFA), recognised on a percentage-of-completion basis; - (d) unit-by-unit apartment sales, recognised at handover. In FY2025, €19.5M of the €147.0M turnover was recognised on a percentage-of-completion basis and €127.5M at a point in time [FY2025 Results PR, Note 4]. **Value-chain position:** Atenor sits at the upstream, risk-bearing end of the value chain: site sourcing, planning permits, design (via international architecture competitions), construction management through general contractors, leasing, and exit. It is not a contractor and does not operate buildings long term. **Customer types:** - Institutional investors and family offices buying finished or forward-funded offices (e.g. Summus Capital for Lakeside, Warsaw; WING for Olympia, Budapest). - Public bodies: the European Commission (Realex conference centre); the Brussels social-housing company SLRB (City Dox lot 5, 171 units). - Corporate occupiers: PwC (Campus, Luxembourg); E.ON Hungária (BakerStreet I); IWG/Regus (Alizé, Paris region). - Banks buying owner-occupied HQs: Caixa Geral de Depósitos (WellBe, Lisbon). - Private households buying apartments (Lake 11 in Budapest, UP-site in Bucharest, City Dox in Brussels). **End-markets:** Urban office development in Belgium, Luxembourg, France, Portugal, Germany and the UK; residential development in Belgium, Hungary, the Netherlands, Luxembourg, Poland and France; formerly offices in Hungary, Poland and Romania (being exited). **Analyst view.** The portfolio's commercial value (Atenor share, on completion) was estimated by management at €3,325M at end-2025, against an inventory book value of €562.8M [FY2025 Results PR]. The investment case therefore hinges on realising latent development margin faster than financing costs erode it. The FY2023–FY2025 record shows that in a high-yield environment the reverse occurred: inventory was written down by €55.9M (FY2023), €36.6M (FY2024) and €41.1M (FY2025), and several assets were sold at a loss [FY2023–FY2025 Results PRs, Note 11].

RevenueN/A
Employees95
Market CapN/A
Founded1910
La Hulpe, Belgium
AtecT&

Atec T& Co., Ltd

Premium
Information Technology

| Item | Detail | Source | |---|---|---| | Current legal name | 주식회사 에이텍모빌리티 / ATEC MOBILITY Co., Ltd. | [S2][S8] | | Former name(s) | 주식회사 에이텍티앤 / ATEC T& Co., Ltd. (2015–Mar 2023) | [S1][S12] | | Founding / incorporation | Established 17–20 July 2015 via spin-off (인적분할) of Atec Co., Ltd.'s transit-card solution division. S&P data lists "founded 1993", which is the founding year of the predecessor/parent Atec Co., Ltd. (KOSDAQ 045660). | [S9][S11][S29][S2] | | Jurisdiction | Republic of Korea (주식회사 under the Korean Commercial Act) | [S1] | | Headquarters | Atec Building, 289 Pangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do 13488, South Korea | [S1][S2][S8] | | Exchange / ticker | KOSDAQ (Korea Exchange) — 224110 (A224110). Listed (re-listed post spin-off) 25 August 2015. | [S1][S2][S8] | | ISIN / CUSIP | no CUSIP (not US-listed) | — | | Fiscal year end | 31 December | [S7][S8] | | Shares issued | 5,340,000 common shares (as of the FY2025 dividend filing, Mar 2026), of which 259,614 were treasury shares. WISEreport now lists 5,080,386 shares issued, which implies cancellation of the treasury shares during 2026 (not independently confirmed). | [S15][S8] | | Share capital | KRW 2.67 bn (par value implied KRW 500/share) | [S10] | | Employees | 272 (30 Jun 2026, per WISEreport/JobKorea); 197–198 enrolled in National Pension Service (Saramin); 503 shown on Korean Wikipedia for the former consolidated group | [S8][S10][S9][S29] | | Auditor | Not publicly disclosed in sources reviewed | — | | Main bank | Woori Bank (Pangyo Techno Valley Center) | [S8] | | Share registrar | Korea Securities Depository | [S8] | | Market capitalization | ≈ KRW 38.1 bn at the close of 15 Oct 2026 (price KRW 7,590) | [S18] | | Representative directors | Shin Seung-young and Choi Sung-yong (co-CEOs, 각자대표) | [S8][S9][S13] | | Parent / group | ATEC group (에이텍 계열). Controlling shareholder Shin Seung-young also chairs Atec Co., Ltd. (045660). | [S11][S29] | | Website | atecmobility.co.kr (formerly atectn.com) | [S8][S1] | The listed entity identified by the supplied details (KOSDAQ 224110; atectn.com; South Korea) is the company formerly named Atec T& Co., Ltd. (주식회사 에이텍티앤). It changed its name to ATEC MOBILITY Co., Ltd. (주식회사 에이텍모빌리티) at its general meeting on 24 March 2023 [S21][S29]. The ticker (224110) and exchange (KOSDAQ) are unchanged. The website has migrated from atectn.com to atecmobility.co.kr (also atecmobility.com) [S2][S8]. Consistent like-for-like headcount data is not publicly disclosed. The available data points are not directly comparable: - consolidated group headcount (503) is from before the mid-2025 divestitures; - the parent-only figure was 272 at 30 June 2026. The CEO stated in July 2025 that R&D staff make up roughly 27% of total employees [S22]. ATEC MOBILITY is a small-cap Korean transit-technology company. It designs, manufactures, installs and maintains automated fare collection (AFC) and transit information equipment: - bus driver and boarding/alighting card terminals; - taxi payment terminals; - railway station automation equipment (gates, ticket vending and top-up machines); - bus information displays; - shared-bicycle smart locks; - related control software. It was spun out of Atec Co., Ltd. in 2015. It built and maintains much of Seoul's transit-card terminal estate and is the maintenance contractor for bus, taxi and top-up terminals installed nationally by T-money, its anchor customer. Between 2017 and 2025 the company was a mini-conglomerate holding an ATM maker (Atec AP) and logistics-automation subsidiaries. It exited these in 2024–2025 and is now a pure-play mobility business: 100% of revenue by H1 2026. Growth levers are: - terminal replacement cycles; - tagless (walk-through) payment, where it holds a government NeT new-technology certification; - C-ITS and autonomous-driving control systems. The business depends heavily on public procurement and on T-money. --- ### What the company does ATEC MOBILITY's core business is RFID-based smart-card transit fare payment terminals: their manufacture, supply, upkeep and repair [S31]. Principal products listed in its corporate summary [S31] are: - transit-card sales and top-up machines; - single-use ticket issuing and top-up machines; - bus driver terminals; - bus boarding/alighting terminals; - express (intercity) bus terminals; - taxi payment terminals. S&P Global's description [S2][S12] states that the company provides: - automated fare payment solutions for buses, railways and taxis; - integrated maintenance services covering taxis, buses, trains, bicycles, kiosks and bus computer networks; - kiosks. A 2026 company profile [S23] describes the service scope as: - fare payment systems for rail, bus and taxi; - bus information systems (BIS); - digital tachographs (DTG); - shared-bicycle smart locks; - autonomous-driving control systems; - kiosks; - maintenance services. That profile frames the core competence as linking payment, operating data, control and maintenance rather than selling hardware alone. ### Company's own characterization **At the 2023 renaming:** [S21]: the company described its main activities as automated fare collection for public transport, smart transport, RFID applications, and development and manufacture of wireless communications equipment. **At the 2015 spin-off:** [S1]: the KRX business report (FY2021 edition) described the company as a transit-card solution specialist. **Earlier corporate copy:** [S9]: emphasised continuous R&D, NeT and green-technology certification, and an ambition to lead in RFID solutions. ### Business model and revenue model The revenue model is predominantly project-based product sales plus recurring maintenance: 1. **Equipment supply contracts.** Large single contracts are awarded by: - T-money (Korea Smart Card Co.) as system operator; - public railway bodies (e.g., Korea National Railway / 국가철도공단); - local governments and transit operators. Examples include KRW 8.26 bn for Incheon bus terminals (2026) and KRW 9.19 bn for 87 Suin-Bundang line stations (2026) [S17][S18]. Payment typically follows milestone schedules (advance / interim / balance) [S18]. 2. **Maintenance and service.** The company is the maintenance contractor for all bus, taxi and top-up terminals that T-money has installed in Korea [S24][S30]. This provides a recurring revenue layer whose size is not separately disclosed. 3. **Software / system integration.** BIS, C-ITS and autonomous-driving control systems (Seoul C-ITS, Sejong autonomous-driving control) are delivered as projects [S34]. A product/service/subscription/licensing revenue split is not publicly disclosed. Licensing revenue is not reported as a separate line. ### Value-chain position The company sits in the equipment and integration layer of Korea's transit-payment value chain: **Upstream:** component suppliers (readers, modules, chips), mostly not disclosed. **Middle (where ATEC MOBILITY sits):** terminal OEMs and integrators. **Downstream:** card-scheme and clearing operators (T-money, Idongui Jeulgeoum/"Ezzle", Hanpay Sys, Korail Rail+, iM U-Pay), transit authorities and operators. The company is not a card issuer or clearing house. It earns equipment and service revenue rather than transaction fees. ### Customer types - Transit-card system operators, principally T-money (주식회사 티머니). - Public infrastructure agencies: Korea National Railway (국가철도공단) and metro operators. - Local governments and public facilities corporations, e.g., Seoul Facilities Corporation for Ttareungyi shared bikes [S20]. - Private mobility and leisure firms: Alton Sports (shared bicycles), CJ CGV (kiosks and photo printers) [S20]. ### End-markets - Urban bus fare collection: Seoul city buses, Gyeonggi village buses, Incheon buses. - Taxi payment, including GPS/app-meter based terminals. - Railway and metro AFC. - Intercity/express bus payment. - Shared micromobility. - Intelligent transport systems (C-ITS, BIS). ### Independent characterization ATEC MOBILITY is best understood as a niche, procurement-driven transit-hardware OEM with a sticky maintenance franchise anchored on T-money's Seoul-metropolitan estate. Its reported financial history from 2017 to 2024 is dominated by a non-core ATM/financial-automation subsidiary (Atec AP). Headline consolidated growth (KRW 201 bn revenue in FY2023) therefore overstates the scale of the mobility business: separate-basis revenue was KRW 38.1 bn in FY2023 [S10]. The 2024–2025 portfolio clean-up has left: - a smaller, more focused company; - an improved standalone operating margin (9.6% in FY2025) [S10]; - a balance sheet with almost no borrowings [S10]. The company remains exposed to lumpy public-contract timing and to concentration on T-money.

Revenue$0.0B
Employees272
Market CapN/A
Founded2015
Seongnam, South Korea
Atec

Atec Co. Ltd.

Premium
Information Technology

The jump from 115 to 300 in FY2024 reflects the staff transferred with the ATM business from ATEC AP (effective 31 August 2024). The FY2024 average salary is depressed because transferred staff were on ATEC's payroll for only four months. Headcount was 110 in FY2021, despite the PC business then being the core operation, because the 2021 transfer of IT outsourcing to ATEC IT and earlier spin-offs had already slimmed the parent [S4]. ATEC is a small-cap Korean maker of financial self-service equipment: cash-recycling ATMs, cash dispensers, teller cash recyclers (TCRs), video teller machines and branch digital desks. The ATM platform traces back to LG Electronics' financial equipment unit (1989), later LG N-Sys and LG CNS, which ATEC and its affiliate ATEC Mobility acquired in 2017 [S6; S4]. Management says ATEC holds about 40% of the Korean ATM market in a two-player structure with Hyosung TNS [S5; S6]. It also says ATEC owns one of the few in-house bill-recycling module technologies outside Japan [S5]. After the 2024 restructuring, ATEC exited its legacy public-sector PC business, now an associate, and pivoted to exports in Portugal, the US retail-ATM channel and other markets. Management targets more than half of revenue from exports [S5]. ATEC is the core listed company of a founder-controlled group (the "ATEC Group") whose related-party transactions drive much of its corporate history. --- **What the company does.** ATEC develops, manufactures, sells and maintains financial automation equipment for banks, financial institutions, retailers and ATM operators. The family includes cash-recycling ATMs, cash dispensers (CDs), teller cash recyclers (TCRs) used inside branches, video teller machines (VTMs), and "digital desks" that combine video consultation with self-service processing [S7; S6; S4]. Since mid-2025 the consolidated group has also included Alpha Engineering (industrial machinery and plant installation, Yangsan) and Taeyang R&P, both acquired through the ATEC AP consolidation [S3; S15]. Overseas sales and service run through subsidiaries in the US (ATEC USA, 75%), Portugal (ATEC Europe, 55%) and Vietnam (ATEC VINA, 100%) [S3, FY2025]. **Company's own description.** ATEC's DART overview describes the business as financial automation equipment ("ATM and others"), logistics automation equipment, LCD monitors and PC manufacturing, and wholesale [S15]. The PC and monitor lines now sit in associate ATEC Computer; the description lags the restructuring. Recruitment profiles describe the company as an "automation platform equipment" maker doing manufacturing, R&D, sales and maintenance [S15]. **Independent characterisation.** ATEC is now a single-product-family capital equipment maker with three revenue streams: 1. **Domestic hardware sales** to Korean banks. This is a mature, shrinking market as branch networks close and cash use falls. 2. **Domestic maintenance and service** on the installed base. This is recurring revenue inherited from the LG-era installed base; the split is not publicly disclosed. 3. **Exports**: Portuguese banks (VTM/ATM), US TCRs and US retail ATMs through ATEC USA, plus Asia (Vietnam, Iran cited in 2025) [S4]. The revenue model is predominantly product sales with an attached service tail. No subscription or software-licensing revenue is disclosed. **Revenue mix (FY2025, as categorised in recruitment-database extracts of the DART report)** [S15] The three ATM lines are not separately named in the extract. About 96% of FY2025 revenue is tied to financial automation. **Value-chain position.** ATEC is an original equipment manufacturer that designs core modules in-house; management highlights the bill-recycling module. Before Korean localisation in 2009 these modules were imported entirely from Japan [S6; S5]. Downstream, ATEC sells directly to Korean banks. Abroad it sells through its own subsidiaries; for example, ATEC USA resells to a US ATM operator [S13]. Major components (displays, PCs, card readers, safes) are bought in, but the supplier base is not disclosed. **Customer types and end-markets.** Korean commercial and special banks: NH NongHyup Bank received ATEC AP digital desks in 2024 [S1 news feed via Mirae Asset, 2024]. Also Portuguese banks (the five largest banks reportedly use mostly ATEC ATMs) [S5], US financial institutions (TCRs) and US retail ATM operators (C3L) [S5; S13]. Customer concentration figures are not publicly disclosed in the sources reviewed.

Revenue$0.1B
Employees387
Market CapN/A
Founded1993
Seongnam, South Korea
AtamValves

Atam Valves Limited

Premium
Information Technology

Atam Valves Limited is a Jalandhar-based, promoter-controlled micro-cap manufacturer of industrial and plumbing valves, fittings and boiler mountings, operating as a single reportable segment. Its catalogue of 500+ products — gate, globe, check, ball, butterfly, plug, safety, pressure-reducing and non-return valves, steam traps, strainers, cocks and boiler accessories in bronze, brass, cast iron, cast steel, forged steel and stainless steel — is sold through 700+ dealers to 300+ institutional clients, overwhelmingly in India (exports ≈3% of revenue in FY2026). After a step-change in FY2023 (revenue +141%) and a record FY2025 (₹60.5 crore revenue), FY2026 revenue fell 21.8% to ₹47.3 crore and net profit fell 61.7% to ₹2.4 crore, with Q3 FY2026 producing the company's first reported quarterly loss as a listed entity. Management's turnaround thesis rests on the API Spec Q1 certification received in 2026, larger-diameter valves (up to 70–72 inches), carbon-steel (WCB) valves, and a targeted rise in export share to 25%. --- ### What the company does Atam Valves designs, casts, machines, assembles, tests and sells flow-control products for liquids, steam, oil and gas. Company filings describe it as being in the business of manufacturing valves and fittings, steam traps and strainers, and as a single-segment company. Company materials (investor presentations, press releases FY2025–FY2026) state that its valves are engineered for service temperatures from –192°C to 550°C and pressures up to 10,000 psi, and that it operates with three specialised foundry shops. Older corporate descriptions (BSE/CMOTS company profile) refer to six workshops, a well-equipped in-house laboratory run by qualified technicians, and a vinyl coating plant for dip-insulating ball-valve handles. The company can design and manufacture valves and bushings to customers' own drawings and specifications. ### Company's own description (latest filings) In its FY2025–FY2026 investor communications, the company describes itself as "a leading manufacturer of industrial and plumbing valves and fittings, catering to various industries such as oil and gas, chemicals, and HVAC," producing gate, globe and ball valves for extreme service conditions, supported by a team of ~500 and three foundry shops capable of handling large and custom orders. The FY2025 Directors' Report (40th Annual Report) states the company's vision as emerging as an efficient producer of valves in the "secondary market," and attributes FY2025 revenue growth to higher manufacturing sales, trading sales and conversion (job-work) activities. The FY2026 investor presentation frames the vision as becoming "a globally trusted leader in industrial valves." ### Business and revenue model | Revenue stream | Description | Disclosure status | |---|---|---| | Manufactured product sales | Own-manufactured valves, boiler mountings, strainers, steam traps under ATAM/FEBI brands | Share of revenue not publicly disclosed | | Trading sales | Resale of bought-out valves/fittings to complete product baskets for dealers and projects | Cited as a growth driver in FY2025 Directors' Report; share not disclosed | | Conversion/job-work income | Machining/conversion activities performed for third parties | Cited in FY2025 Directors' Report; share not disclosed | | Services/subscription/licensing | None identified | Not applicable | The model is a classic Indian mid-tier industrial-component model: product revenue (100% product/job-work; no recurring service, subscription or licensing component), dealer-led distribution for plumbing/MRO volume, and direct/tender-based supply to EPC contractors, PSU refiners, power utilities and OEMs for project volume. ### Value-chain position Atam is vertically integrated from casting (own foundries for bronze/gunmetal, cast iron and steel) through CNC machining, assembly, hydrostatic/pneumatic testing and coating. It is upstream of EPC contractors, plant owners and plumbing contractors, and downstream of metal (copper alloy, cast iron, carbon steel, stainless steel) suppliers. The company has stated an intention to move from Chinese brass inputs to higher-grade stainless steel to improve durability (June 2025 trade-press interview). ### Customer types and end-markets | Customer type | Examples (as cited in secondary profiles) | |---|---| | Oil & gas refiners / marketing companies | IOCL, BPCL, HPCL, Essar | | Power utilities / equipment | NTPC, BHEL, Thermax | | Conglomerates / infrastructure | Adani | | Water treatment / process | Driplex | | Industrial / transformers / textiles | Voltamp, Alps Industries | | Rail / institutional | IRCTC | | Real estate & healthcare plumbing | Residential and commercial projects in Kolkata, Mumbai, Thane, Gujarat, Rajasthan, Indore, Cochin and Calicut (company statement, June 2025) | | Dealers | 700+ dealers (company disclosure via Screener key points) | End-markets named across company materials: oil & gas, petrochemicals, chemicals, power, HVAC, water treatment, textiles, infrastructure, real estate plumbing, healthcare facilities, and boiler/steam systems. ### Independent characterisation Atam is best understood as a sub-scale, broad-line, low-to-mid specification valve maker whose historic franchise lies in bronze/gunmetal valves, boiler mountings and plumbing-grade ball valves sold through dealers in North India, with an expanding but still small project/PSU business. Its working-capital profile (inventory days above 400 at FY2026 year-end on our calculation) is characteristic of a company carrying a very broad SKU catalogue for dealer availability. The FY2026 earnings collapse suggests limited pricing power and high operating leverage at this scale. The API Spec Q1 certification is the company's first credible attempt to enter the higher-value, specification-driven oil & gas segment, but the company has not yet disclosed API Monogram (product-specific, e.g., API 6D/600) licences, which are typically required for refinery/pipeline tenders.

Revenue$0.0B
Employees500
Market Cap$0.0B
Founded1982
Punjab, India
ATAL

ATAL REALTECH LTD

Premium
Information Technology

Atal Realtech is a Nashik-based civil-construction contractor run by its promoters. It executes government-funded buildings and infrastructure in Maharashtra. It holds Class I-A contractor registration with the Maharashtra Public Works Department (PWD), which makes it eligible to bid for the state's larger civil tenders. Its work spans water supply and drainage, roads and bridges, irrigation, and public buildings: courts, rest houses, hospitals, stadiums, educational institutions and mass housing. The business began mainly as a subcontractor executing work won by larger principal contractors, historically Prakash Constrowell Ltd. It now also bids directly as the lowest-price (L1) bidder on PWD tenders and takes back-to-back subcontracts from ABH Developers. Revenue rose from about ₹40 cr (FY2022–FY2024) to ₹120 cr in FY2026, and the order book reached ₹217.57 cr. However, scaling has consumed large amounts of working capital, operating cash flow has been negative for two years, and the equity carries high governance and liquidity risk. --- ### The company's own description Exchange filings and offer documents describe Atal Realtech as a provider of integrated contracting and subcontracting services for civil and industrial construction, engineering and full infrastructure project management. The company states that it is a registered Class I-A contractor with the Government of Maharashtra PWD and lists these project types: - Water supply and drainage - Roads and bridges - Major and minor irrigation - Civil construction: indoor and outdoor sports stadiums, multi-purpose halls, commercial and industrial structures, hospitals, cold storages, educational institutions and mass-housing projects (Source: company business overview reproduced on Screener; FY2025 integrated annual report context.) The offer documents also note that the company has historically subcontracted work for government and private projects, mainly with Prakash Constrowell Limited. They describe the promoter, Vijaygopal Atal, as a civil engineer with long experience in government construction and the main driver of the company's strategy. (Source: IIFL company summary of offer documents.) The FY2026 description (Screener summary of the FY2025-26 annual report) adds that the wholly owned subsidiary Atal Realty Ltd marks the company's entry into real estate and land development. ### Business model and revenue model | Dimension | Characterisation | |---|---| | Revenue type | About 100% project/service revenue from construction contracts, recognised over time as work is completed and certified. No product, subscription or licensing revenue is disclosed | | Contract forms | (1) Direct government contracts won as L1 bidder (for example the PWD Nashik rest-house order, ₹24.92 cr, July 2026). (2) Back-to-back subcontracts from principal contractors (for example ABH Developers' Karanja court building, ₹49.47 cr principal value, with a 4% royalty payable to ABH). (3) Historical subcontracting for Prakash Constrowell Ltd | | Pricing | Item-rate or lump-sum tender pricing set by public procurement. Margin depends on the bid spread, input-cost changes and execution speed. Specific escalation clauses are not publicly disclosed | | Customers | State government departments and agencies, chiefly Maharashtra PWD and the National Health Mission (Washim). Also principal EPC contractors and private developers | | End-markets | Public buildings (judicial, administrative, hospitality/rest houses, healthcare, education, sports), water and sanitation, irrigation, roads and bridges | | Value-chain position | Mid-tier execution contractor. It does not own concessions (no BOT/HAM assets), does no design-build on the scale of large EPC firms, and runs no meaningful in-house materials manufacturing. Labour is largely outsourced: the company reports about 23 employees against ₹120 cr of revenue | | New adjacency | Real estate and land development through Atal Realty Ltd (incorporated June 2025). Its contribution to revenue is not separately disclosed and appears immaterial so far | ### Independent characterisation In practice, Atal Realtech is a working-capital-intensive, single-state, single-segment public-works contractor in the middle of a step-change in scale: **Revenue:** about ₹40 cr per year in FY2022–FY2024, rising to ₹95.7 cr in FY2025 (+134%) and ₹120.05 cr in FY2026 (+25.4%). **Order book:** ₹217.57 cr across 21 live projects at 30 June 2026, about 1.8× FY2026 revenue. The growth has come from moving away from dependence on one principal contractor towards direct PWD tenders and a new back-to-back relationship with ABH Developers. The financial signature is typical of a fast-growing small contractor: - Gross margins of 14–21%. - EBITDA margins of 8–13%. - Thin net margins of 4–5.5%. **Deeply negative operating cash flow during the scale-up:** (about –INR 143 M in FY2025 and –INR 194 to –214 M in FY2026, depending on source). - Repeated equity raises to fund it: a ₹25.90 cr rights issue in 2024, and a ₹16 cr rights issue approved in August 2026 and withdrawn in October 2026.

Revenue$0.0B
Employees23
Market CapN/A
Founded2012
Nashik, India
AT

AT & S Austria Technologie & Systemtechnik Aktiengesellschaft

Premium
Information Technology

FY2022/23–FY2024/25 year-end headcounts were not captured in the releases reviewed. The 31 Dec 2024 figure was 13,204. The interim decline to 13,051 at 30 Sep 2025 reflects the deconsolidation of Ansan, Korea (sold January 2025) and the cost programme. AT&S is Europe's largest, and the Western world's only scaled, manufacturer of high-end IC substrates. It is also a top-tier producer of advanced printed circuit boards (HDI, mSAP/substrate-like PCBs, embedded-component boards). The company sits at the interface between semiconductor packaging and electronic system assembly. It supplies the ultra-fine-line interconnect platforms on which leading-edge processors, AI accelerators and server CPUs are mounted, and the dense boards inside smartphones, wearables, vehicles, medical devices and industrial equipment. More than three-quarters of revenue comes from US-headquartered customers and most sales are denominated in US dollars, while the cost base is spread across Austria, China, Malaysia and India. After a punishing 2023–2025 down-cycle financed by a ~€3.5bn capacity build-out, AT&S has re-rated into an AI-infrastructure play. Long-term, customer-financed capacity agreements with AMD and Marvell now underpin a €1.5–2.0bn Kulim expansion and guidance for 45–55% currency-adjusted revenue growth in FY2026/27. --- **What the company does.** AT&S designs and manufactures two families of interconnect products: 1. **IC substrates.** These are multilayer, ultra-high-density carriers that sit between a semiconductor die (or a set of chiplets) and the system PCB. They fan out thousands of micro-bumps at the die side to a coarser pitch the motherboard can accept. AT&S focuses on ABF-based flip-chip ball-grid-array (FC-BGA) substrates for high-performance computing (CPUs, GPUs, AI accelerators, networking ASICs). This requires large body sizes, high layer counts, fine line/space, and increasingly advanced cores and embedded structures. 2. **Advanced printed circuit boards.** These include high-density interconnect (HDI) and any-layer boards, modified semi-additive process (mSAP) "substrate-like" PCBs for smartphones and wearables, and boards for automotive (ADAS, radar, power electronics, e-mobility), industrial, medical and aerospace. The PCB range also covers embedded-component packaging (ECP) and module integration. **Company's own description (FY2025/26 boilerplate in results releases).** AT&S describes itself as a leading global manufacturer of high-end IC substrates and printed circuit boards. It cites production sites in Austria (Leoben, Fehring), China (Shanghai, Chongqing), Malaysia (Kulim) and India (Nanjangud), plus a European competence centre for R&D and IC-substrate production in Leoben. It serves mobile devices, automotive, industrial, medical and high-performance computing for AI. (Source: AT&S EQS releases, 30 Sep 2025 and 13 Jun 2026.) **Business model.** AT&S is a build-to-print / co-development manufacturer. It does not sell catalogue products. Each board or substrate is engineered to a customer's design, qualified over 6–24 months, and then produced in volume under multi-year programmes. Revenue is almost entirely product revenue (manufactured units). There is no material subscription, licensing or service revenue, although engineering co-development and module assembly are bundled into pricing. A distinctive feature of the model since FY2021/22 is customer-financed capacity. Under bilateral agreements, customers pre-pay or co-fund dedicated production lines. AT&S received €446M of such payments in FY2021/22 (FY2021/22 results release). The 2026 Kulim and Chongqing expansions are described as "fully supported and financed by long-term customer commitments" (ad-hoc, 13 Jun 2026; Q1 2026/27 release). **Value-chain position.** **Customer types.** Global semiconductor companies (substrates). Smartphone and consumer-device OEMs, tier-1 automotive suppliers, industrial and medical OEMs, and, since FY2025/26, defence and security customers (PCBs). According to APA/Vienna Stock Exchange reporting (Feb 2026), more than three-quarters of revenue is with US companies and the majority is generated in US dollars. Named customers in primary releases: AMD (13 Jun 2026) and Marvell Technology (22 Sep 2026). Other major customers (e.g., Apple, Intel) are widely reported in the press but not confirmed in AT&S releases reviewed. Reuters (15 Jun 2026) cited industry sources naming Intel as the unnamed second Kulim customer; AT&S later identified that customer as Marvell (22 Sep 2026), so the Reuters attribution appears to have been incorrect. **End-markets.** Data centre/server/AI accelerators (described as the growth driver in the H1 2025/26 release), mobile devices and wearables, PCs/notebooks, automotive, industrial, medical and healthcare, aerospace (Leoben holds Nadcap accreditation per aggregator data), and defence/security (entered Sept 2025). **Independent characterisation.** AT&S is now best understood as a two-speed company. The first is a mature, cash-generative but price-pressured PCB franchise (Electronics Solutions). The second is a capital-hungry, operationally geared IC-substrate business (Microelectronics) whose fortunes are tied to AI/HPC package complexity. In FY2025/26 Microelectronics revenue grew 53% (investor presentation summary, Quartr, May 2026). The FY2026/27 guidance step-up is driven almost entirely by substrates. The economics resemble a semiconductor-equipment-intensive foundry more than a classic PCB shop. Utilisation drives margins (start-up costs depressed EBITDA by several points in FY2021/22–FY2024/25), and FX (USD revenue against EUR/MYR/CNY costs) is a first-order earnings variable.

Revenue$2.0B
Employees14,301
Market CapN/A
Founded1987
Leoben, Austria
Asya

Asya Infosoft Limited

Premium
Information Technology

Axis Solutions Limited is an Ahmedabad-based process-analytics, instrumentation and industrial-automation engineering company that re-entered the public market in July 2025 through an insolvency-led reverse merger into the listed shell of Asya Infosoft. Its core franchise is engineered analyser systems used in hazardous, regulated industrial environments: continuous emission monitoring systems (CEMS), steam and water analysis systems (SWAS), gas analysis systems, analyser shelters, purge panels and flameproof HVAC. These products are sold to refineries, petrochemical complexes, power plants, steel, cement and fertiliser producers, and water utilities. On this base the company is building three layers: a water-infrastructure EPC and monitoring business tied to India's Jal Jeevan Mission; IIoT and cloud monitoring platforms (AxisCloud, AquaVision, SmartShelter); and pre-revenue "Axis 2.0" bets in solid-state hydrogen storage, EV charging and railway Kavach. FY2026 revenue was ₹240.7 Cr with a ~19% EBITDA margin. The equity trades at roughly 90x trailing earnings, which prices in management's ₹1,000 Cr FY2029 revenue ambition. --- ### What the company does Axis Solutions designs, manufactures, integrates, tests, commissions and maintains analytical measurement and automation systems for process industries. Credit-rating material describes it as an Ahmedabad-headquartered maker of analytical and analyser system solutions, CEMS, SWAS, HVAC systems and water sensors for a wide range of industries, operating three manufacturing, integration, testing and inventory facilities in Ahmedabad (CRISIL, 7 Oct 2026). The company's own investor presentation (2026) describes six manufacturing units across roughly 1.4 lakh sq ft. The company frames itself as a single-vendor, end-to-end provider. In its telling, it can cover the entire chain from the sample probe on a live process line, through sample conditioning and analysis, thermal and environmental protection (shelters, HVAC) and connectivity, up to cloud dashboards and regulatory reporting. It addresses this chain through seven product categories across five priority industries: steel, natural gas, refineries and petrochemicals, "MODRN" (as labelled in the deck), and water (investor deck as summarised by Zenflow Research, Sep 2026). ### Company's own description The company's materials describe Axis as a BSE-listed engineering and manufacturing company providing analytical instrumentation, process automation, industrial shelters, hazardous-area HVAC, environmental monitoring, SWAS and Industry 4.0 solutions for oil and gas, petrochemical, power, water and process industries (company website, 2026). Its recent press releases describe it as an Indian engineering and deep-tech enterprise with more than 27 years of operating experience (press release, Oct 2026). The 27 years refers to the private operating business founded in 1999, not to the listed entity's own track record. ### Business and revenue model | Engine | Description | Revenue character | |---|---|---| | Axcelence | Representation and partnership with global instrumentation brands in India (e.g., Panametrics, Teledyne, Bühler, Seneca, Leonton; elsewhere Knick, ADFWeb, Stego among 14+ brands) | Traded/partner product sales; lower value-add | | Axociate | Distribution business built around the "Brix" network | Distribution margin; reach without full customer ownership | | Axcelerator | Proprietary manufactured products: Baspa, AMISON, Typhoon, Snowind, W-BRIx/i-BRIx/e-BRIx | Highest margin; AMC, spares and upgrade annuity | Management describes three commercial "engines" (investor deck, 2026): Revenue is overwhelmingly project and product based. Most of it is recognised on milestone billing for engineered systems and EPC-style water projects, with retention money withheld until completion (CRISIL, 2026). Service and annuity revenue (AMCs, spares, multi-year O&M) exists. One example is a 10-year maintenance commitment on L&T's Uttar Pradesh Jal Jeevan Mission (JJM) projects. The split between product, service, subscription and licensing revenue is not publicly disclosed. Raw materials account for 55–60% of operating revenue (CRISIL, 2026), which implies a gross margin in the region of 40–45%. ### Value-chain position Axis sits between global analyser and instrument OEMs (whose sensors it often integrates or represents) and EPC contractors or plant owners (who buy fully engineered, certified, tested systems). Its differentiating capabilities are system engineering, hazardous-area certification (ATEX, IECEx, PESO), shelter and HVAC fabrication, and integration of these into a single package. In water, it also acts as an EPC sub-contractor to larger joint ventures (NKG Primus JV, Sarala Projects Works, Vikran Engineering). ### Customer types and end-markets | Customer type | Named examples (company materials) | |---|---| | Indian industrial majors | Reliance, Adani, Aditya Birla Group, Tata Chemicals, Vedanta, Grasim Industries, Mundra Petrochemicals | | Automation/OEM primes | ABB, Emerson, Honeywell, Schneider Electric, Siemens, Siemens Energy India, Yokogawa, Thermax | | EPC contractors | L&T, NKG Primus JV, Sarala Projects Works, Vikran Engineering, a Germany-based EPC (UAE DRI project), John Cockerill Hydrogen Belgium SA | | PSUs / government | BHEL, NTPC, SAIL, Brahmaputra Cracker & Polymer Ltd (BCPL), NKG Jal Nigam (UP) | | International energy companies | ADNOC, QAFCO, PDO, Petronas, Sonatrach | End-markets are oil and gas, refineries and petrochemicals, power, steel, cement, fertilisers and chemicals, water and wastewater (industrial and municipal), and, prospectively, hydrogen, rail, defence and marine. **Concentration is rising.** The top-10 customers' share of revenue increased from 44% in FY2024 to 61% in Q1 FY2027. Over the same period the top-20 share rose from 59% to 74% (investor deck, as reported by Zenflow Research, Sep 2026). ### Independent characterisation Stripped of the narrative, Axis is a small, working-capital-intensive, project-based instrumentation integrator. It has genuine technical qualifications, notably hazardous-area certifications and vendor approvals with global energy companies. It currently makes most of its money from two sources: engineered analyser and shelter packages, and increasingly large, low-technology water-supply EPC sub-contracts. Recent order intake (₹800 Cr+ in Q2 FY2027, mostly water EPC) will move the mix further toward EPC, with implications for margins and receivables. The "deep-tech" verticals (hydrogen, EV charging, Kavach) contributed no material revenue as of the latest disclosures.

Revenue$0.0B
Employees240
Market CapN/A
Founded1999
Ahmedabad, India
Astron

Astron Paper & Board Mill Limited

Premium
Information Technology

Astron Paper & Board Mill was built as a mid-sized, Gujarat-based maker of recycled kraft paper. It converted imported waste paper (old corrugated containers) into kraft liner, test liner, fluting medium and high-RCT grades for India's corrugated-box industry. Its anchor demand came from the Morbi ceramic-tile cluster, where co-promoter Asian Granito operates. After a heavily oversubscribed IPO in 2017, it scaled rapidly through three moves: - a second paper machine at Halvad; - a bank-auction purchase of a Bhuj mill; - the acquisition of Balaram Papers in Mehsana. At peak this gave roughly 222,000 MTPA of disclosed capacity and ₹513 Cr of revenue (FY2022). Price competition, input-cost volatility, rising leverage and liquidity stress then produced losses from FY2023. The Halvad plant was shut on 8 September 2024 and never reopened. The company is now a non-operating corporate debtor in CIRP: its lenders have enforced security under SARFAESI, and creditors are soliciting resolution plans due 16 November 2026. Equity value is effectively an option on the resolution outcome. --- **Company's own description.** The FY2025 annual report and exchange profiles describe the company this way: - It is one of the larger manufacturers of recycled corrugated paper in its region. - It produces kraft paper from waste paper in grades of 80–350 GSM (grams per square metre) and burst factor (BF) of 16–40. - Its products serve the packaging industry for corrugated boxes, liners, sacks and composite containers. - Its dominant revenue source is the sale of kraft paper. **Business model.** The model was a single-product, commodity manufacturing business: **Inputs:** imported recovered paper (the company stated it sourced 100% imported waste paper), plus coal and other fuel for captive steam and power. **Process:** pulping, cleaning and forming on four paper machines across three sites in Gujarat. **Sales:** reels and sheets sold to corrugated-box makers, mainly in western India, with some exports to the Middle East, Iran, Sri Lanka, Bangladesh, Africa and South-East Asia. **Revenue model.** **Value-chain position.** Astron sat in the mid-stream of the paper-packaging chain: Recovered paper collectors and importers → kraft paper mill (Astron) → corrugated-box converters → end-users End-users included ceramics and tiles, FMCG, pharmaceuticals, e-commerce, textiles, agriculture and industrial goods. The company had no forward integration into boxes and no backward integration into pulp. Margins were therefore the spread between kraft paper realisations and waste paper plus energy costs. That spread is highly cyclical and driven by China's recovered-paper import policy, global OCC prices, freight, and Indian capacity additions. **Customer types.** Customers were corrugated-box manufacturers and packaging converters, reached directly and through dealers. No single-customer concentration is publicly disclosed. **End-markets.** Indian corrugated packaging was the main end-market, with particular exposure to the Morbi ceramic-tile packaging cluster (Halvad is in Morbi district). Export markets were listed above. **Independent characterisation.** Astron was a sub-scale, undifferentiated recycled-kraft producer competing in a fragmented, oversupplied Gujarat market. Its working-capital-intensive model left it with no pricing power and no cost advantage: - receivable days were roughly 60–78 before the shutdown; - it depended entirely on imported fibre, exposing it to currency and freight swings. When spreads compressed in FY2023 and liquidity tightened in FY2024–25, it lacked the balance-sheet resilience to idle and restart capacity. Today it has no operating business. Its residual value lies in land, buildings and machinery at Halvad and Bhuj (both under lender possession) and in its shareholding in the Balaram Papers subsidiary.

Revenue$0.0B
Employees411
Market CapN/A
Founded2010
Ahmedabad, India
AstraZeneca

AstraZeneca Pharma India Limited

Premium
Information Technology

AstraZeneca Pharma India Limited is the publicly listed Indian commercial arm of AstraZeneca PLC, operating as a specialty, innovation-only pharmaceutical marketer focused on Oncology, Biopharmaceuticals (Cardiovascular, Renal & Metabolism; Respiratory & Immunology; Vaccines & Immune Therapies) and, since FY2025, Rare Disease (Alexion portfolio). Unlike India's generic-led majors, AZPIL sells patented and branded medicines sourced predominantly from its parent's global supply network, and it has now completed its exit from in-country manufacturing (Bengaluru site). Revenue has compounded at roughly 30% a year since FY2022, reaching INR 22,756 M in FY2026, driven overwhelmingly by oncology brands, which grew 44% to INR 16,101 M. The company secured 11 regulatory approvals for new medicines and indications in FY2026. The investment case combines best-in-class top-line growth and a debt-free balance sheet against thin, compressing margins, heavy related-party sourcing, price-control exposure, recent senior-management turnover, and a valuation near 100x trailing earnings. --- ### Company's own description Exchange-filed descriptions characterise the company as engaged in the manufacture, distribution and marketing of pharmaceutical products, and also as a provider of clinical-trial services to an overseas group company (FY2025 Annual Report, as quoted by aggregators). The company's October 2026 press release describes the AstraZeneca organisation in India as science-led, focused on discovery, development and commercialisation of prescription medicines across Oncology, Biopharmaceuticals and Rare Disease, with operations in India spanning commercial operations, site management and clinical monitoring, technology, R&D and global business services. ### Independent characterisation AZPIL is best understood as a "pipeline-import, commercialise-locally" model: 1. **Product sourcing.** Finished medicines are imported from AstraZeneca group entities (principally AstraZeneca AB, Sweden and AstraZeneca UK). Related-party transactions with these entities were reported by one analysis at about 72.9% of FY2025 revenue (CompoundingAI, Q1 FY2027 results note) — this is the scale of related-party flows (mostly purchases), not revenue from those parties. AZPIL is Marketing Authorisation Holder (MAH) and import-licence holder in India for the molecules it markets. 2. **Regulatory gateway.** AZPIL files for import and marketing permission with India's Central Drugs Standard Control Organisation (CDSCO) for each new molecule or indication from the global pipeline. FY2026 saw 11 approvals; the group cites 25+ new medicines/indications launched in India over three years (press release, 16 Oct 2026). 3. **Commercialisation.** Specialty field force calling on oncologists, cardiologists, nephrologists, pulmonologists and hospital formularies, increasingly supplemented by brand-partnership (co-marketing) agreements with large domestic companies (Sun Pharma, Mankind Pharma) for mass-market molecules where AZPIL lacks reach. 4. **Services revenue.** Clinical-trial services provided to an overseas group company (the group runs about 80 global clinical trials in India per October 2026 release). 5. **Manufacturing.** Historically a tablet manufacturing/packaging site at Yelahanka, Bengaluru. Exit announced Nov 2023; manufacturing licence surrendered Sept 2025; exit completed during FY2026. ### Revenue model mix | Revenue type | Description | FY2026 disclosure | |---|---|---| | Product sales (patented/branded Rx) | Oncology, Biopharmaceuticals, Rare Disease brands | ~INR 21,559 M across three therapy areas (computed from disclosed TA revenue) | | Services | Clinical-trial services to group company | Not separately disclosed in materials reviewed | | Licensing / distribution fees | Upfront/consideration from co-marketing partners (e.g., INR 260 M payable under the Nov 2025 Sun Pharma SZC agreement) | — | | Subscription | None | n/a | ### Customers and end-markets **Direct customers:** pharmaceutical distributors/stockists (C&F agents), hospitals and institutional buyers (including government tenders for some brands), and co-marketing partners (Sun Pharma, Mankind Pharma) to whom AZPIL supplies product. **Prescribers:** medical/surgical oncologists, haemato-oncologists, cardiologists, nephrologists, endocrinologists/diabetologists, pulmonologists, rare-disease specialists. **End-market:** the Indian Pharmaceutical Market (IPM), specifically the premium innovator/specialty segment, which is a small share of the generics-dominated IPM by volume but growing faster in value. Patient affordability is a constraint; most oncology therapy is out-of-pocket or insurance-funded, with patient-access programmes playing a material role. ### Value-chain position AZPIL sits at the last mile of AstraZeneca's global value chain: discovery, development and manufacturing occur largely outside the listed entity; AZPIL captures a distribution/commercialisation margin governed by transfer pricing with the parent.

Revenue$0.3B
Employees760
Market CapN/A
Founded1979
Bengaluru, India
Astral

Astral Poly Technik Limited

Premium
Information Technology

Astral is India's pioneer and category leader in CPVC (chlorinated PVC) plumbing systems, having introduced CPVC piping to the Indian market in partnership with Lubrizol's FlowGuard technology, and has since evolved into a diversified polymer-based building-materials platform. Its core Plumbing segment — pipes, fittings, water tanks, valves and bathware — generated roughly 70% of FY2026 consolidated revenue and carries what brokers describe as the highest segment EBITDA margin in the Indian plastic-pipe industry (18.9% in Q1 FY27), owing to a value-added mix skewed towards CPVC, PEX, multilayer and low-noise drainage products rather than commodity agri pipes. The Paints & Adhesives segment (Resinova, BondTite, Bond It UK, Astral Paints) adds a consumer-chemicals growth leg. The company is net-cash, founder-led (promoters hold ~54.2%), and is now investing in backward integration into CPVC resin (40,000 MT plant, trial runs Q4 FY27) and specialty chemicals (DSS LLP). --- **What the company does.** Astral manufactures and markets polymer-based building products in India and, through subsidiaries, in the UK, Ireland and the USA. It reports two segments: (a) Plumbing — CPVC and PVC pipes and fittings, fire-sprinkler systems, soil-waste-rainwater (SWR) drainage, underground drainage and infrastructure piping (drainage, cable protection, post-tensioning ducts), agricultural pipes, specialised valves, water storage tanks, and bathware (faucets and sanitaryware); and (b) Paints and Adhesives — industrial and consumer adhesives and sealants, construction chemicals (waterproofing, tile adhesives, grouts), DIY products, and decorative paints. **Company's own description (paraphrased from FY2025-26 disclosures and press releases).** Astral describes itself as one of India's leading building-materials companies with a diversified presence across essential construction and infrastructure categories, having started with a focused pipes-and-fittings offering and systematically added adhesives, sealants, water storage, bathware, valves, paints, construction chemicals and infrastructure products. **Independent characterisation.** Astral is best understood as a branded, distribution-led, asset-moderate manufacturer whose economic moat rests on (i) first-mover CPVC brand equity with plumbers and consultants, (ii) a decentralised plant footprint (21 manufacturing units, ~5.97 lakh TPA aggregate capacity at FY2026) that lowers freight cost on a bulky product, (iii) heavy brand investment (IPL team sponsorships, celebrity ambassadors), and (iv) a product mix tilted away from commodity agricultural PVC. Earnings sensitivity is dominated by PVC resin price cycles (inventory gains/losses), which periodically swamp underlying volume growth. **Revenue model.** Effectively 100% product sales (manufactured goods). No material service, subscription or licensing revenue is disclosed. Sales are made predominantly through a multi-tier channel (distributors → dealers/retailers → plumbers/contractors), supplemented by institutional/project sales (real estate developers, infrastructure, industrial buyers) and, in adhesives, OEM/industrial accounts. **Value-chain position.** Midstream converter: buys PVC/CPVC resin and compound, additives, and chemical intermediates; extrudes/moulds finished goods; sells through channel. Backward integration is underway (CPVC resin via Nexelon Chem, 80%; specialty chemical intermediates via DSS LLP, 60%). **Customer types and end-markets.**

Revenue$0.8B
Employees4,881
Market CapN/A
Founded1996
Ahmedabad, India
Astral

Astral Limited

Premium
Information Technology

Astral Limited is India's pioneer and category leader in CPVC (chlorinated polyvinyl chloride) plumbing systems and has evolved into a diversified, brand-led building-materials platform. From a single-product CPVC pipe business launched in the late 1990s, it now spans pipes and fittings (CPVC, uPVC, PPR, drainage, agricultural and infrastructure pipes), water tanks, bathware, valves, adhesives and sealants (Resinova in India, Seal IT/Bond It in the UK and Ireland), construction chemicals and decorative paints. FY2026 consolidated revenue was INR 6,569 cr, with plumbing contributing roughly 71%. The company's moat rests on brand equity, a premium value-added product mix, a pan-India manufacturing footprint designed to minimise freight, a deep distributor and plumber network, and a net-cash balance sheet. Its strategic arc for FY27–FY30 is vertical integration (captive CPVC resin from December 2026), market-share gains in plumbing, and scaling the chemicals and paints vertical toward INR 4,400–5,000 cr of revenue. --- ### What the company does Astral manufactures and markets polymer-based building materials. It reports two operating segments: 1. **Plumbing** — pipes, fittings, water tanks and bathware (and, operationally, valves and infrastructure/drainage products). 2. **Paints and Adhesives** — the erstwhile Resinova Chemie business (Indian adhesives, sealants and construction chemicals), Seal IT Services (UK adhesives and sealants, with Bond It Ireland and a US entity), and Astral Chemie Limited (formerly Astral Coatings Private Limited, formerly Gem Paints), which houses decorative paints. The company's own segment definitions in quarterly press releases describe Plumbing as "pipes, fittings, water tanks, bathware" and Paints & Adhesives as "erstwhile Resinova + Seal It + Astral Coatings Private Limited (Gem)". In its corporate boilerplate Astral describes itself as one of India's leading building materials companies, which started with pipes and fittings and has systematically added adhesives, sealants, water storage solutions, bathware, valves, paints, construction chemicals and infrastructure products. ### Business and revenue model Astral's revenue is almost entirely product revenue from manufactured goods sold through a multi-tier distribution channel (distributors → dealers/retailers → plumbers, contractors, builders, and institutional/project buyers). There is no material subscription, licensing or service revenue. The FY26 BRSR states that pipes, fittings and adhesives together account for about 98% of standalone turnover. Key features of the model: **Brand-led premium positioning:** Astral is a heavy spender on brand-building; S&P data show advertising expense of INR 2,297m in FY26 (3.5% of revenue), up from INR 1,251m in FY22. **Value-added product mix:** CPVC, which commands higher realisations and margins than commodity uPVC, is the core of the plumbing franchise. Sharekhan estimates Astral's share of India's CPVC pipes market at 25–30%. **Regionalised manufacturing:** Pipes are freight-heavy and low value per cubic metre; Astral has deliberately built plants in each major region (west, south, north, east, central) to reduce logistics cost and improve service. **Pass-through pricing:** Raw materials (PVC resin, CPVC compound, polymers, chemicals) are the largest cost line. Astral generally passes price changes through to the channel with a lag, which creates inventory gains or losses when polymer prices move sharply. **Low working capital:** Strong channel power allows Astral to collect quickly; trade receivables were ~26 days of sales at FY26 year-end (derived), and payables broadly fund inventory. ### Value chain position Astral sits in the midstream: it buys resin and compound (historically CPVC compound from global suppliers such as Lubrizol, plus domestic and imported PVC), converts it into pipes and fittings, and sells branded products downstream. It is now integrating backward into CPVC resin (Nexelon Chem, 40,000 MT phase-I plant targeted for December 2026) and into specialty chemical intermediates for adhesives (DSS LLP — polyamines, bismaleimides, benzoxazines). ### Customer types and end-markets | End-market | Products | Demand drivers | |---|---|---| | Residential real estate (new build and replacement) | CPVC/uPVC plumbing, drainage (SWR), water tanks, bathware, adhesives, paints | Housing completions, urbanisation, renovation cycles | | Commercial & institutional (hospitals, hotels, malls, offices, stadiums, government buildings) | CPVC hot/cold plumbing, fire sprinkler systems, drainage, industrial piping | Commercial construction, fire-safety regulation | | Infrastructure & water | Underground drainage, corrugated pipes, column/borewell pipes, O-PVC | Jal Jeevan Mission, AMRUT, smart cities, sewerage | | Agriculture | Agri pipes, column pipes | Irrigation, rural water | | Industrial | Industrial CPVC piping, valves, adhesives | Chemical process industries, manufacturing | | Woodworking, furniture, DIY | Adhesives (Resinova), sealants | Furniture, interiors, retail DIY | | UK/Ireland trade and DIY | Sealants, adhesives, fillers (Seal IT/Bond It) | UK RMI (repair, maintenance, improvement) market | ### Independent characterisation Astral is best understood as a premium consumer-facing building-products franchise with a commodity-input cost base. In plumbing, it behaves like a branded FMCG-style distributor of durable goods: it consistently gains share in weak markets (FY26 industry volumes fell ~9–10% while Astral grew volumes ~14–16%), earns the highest plumbing EBITDA margin among listed peers (18.9% in Q1 FY27), and generates strong returns on capital. The adhesives and paints vertical is a sub-scale, still-investing portfolio whose margins (8.7% segment EBITDA margin in Q4 FY26 and Q1 FY27) dilute group returns. The market's central debate is whether the chemicals vertical will become a second growth engine or a persistent drag; the company's June 2026 decision to demerge it, followed by withdrawal one month later, sharpened that debate.

Revenue$0.8B
Employees11,141
Market CapN/A
Founded1996
Ahmedabad, India
AstralFoods

Astral Foods Limited

Premium
Information Technology

Astral Foods is South Africa's largest vertically integrated poultry producer. By its own estimate it held about 27% of local broiler production in H1 FY2026, slaughtering about 6.1 million birds per week from a national total of about 22.3 million [S5]. The group controls the full chain: - Ross 308 broiler genetics through Ross Poultry Breeders - Day-old chick supply through National Chicks - Feed milling through Meadow Feeds' seven mills - Breeder and broiler farming - Abattoir and further processing - Branded sales under Goldi, County Fair, Festive, Mountain Valley and Earlybird Its stated strategy is to be the best-cost integrated poultry producer in selected Southern African countries [S5]. The model is highly operationally geared to two variables: feed raw-material costs (feed is about 66% of broiler live cost) and chicken selling prices [S1]. That gearing explains the sharp swing in profit: The balance sheet now holds net cash, which the company says can fund growth. --- ### Company's own description In its FY2025 results, Astral describes itself as a leading South African integrated poultry producer. Its listed key activities are: - Animal feed manufacturing - Broiler genetics - Production and sale of day-old chicks and hatching eggs - Integrated breeder and broiler production - Abattoirs - Sale and distribution of its poultry brands [S1] The corporate website and results presentations state the strategy as being the best-cost integrated poultry producer in selected Southern African countries. Management reconfirmed this strategy in February 2025 [S5]. ### Independent characterisation Astral is effectively a commodity-conversion business. It converts maize and soya into chicken protein through a closed genetics-to-plate chain. Value is created mainly in four ways: **Feed conversion efficiency:** Chicken has a feed conversion ratio of about 1.4, versus 2.2 for pork and 5.5 for beef, per industry data presented by Astral [S5]. **Fixed-cost absorption:** Running abattoirs and feed mills at maximum throughput spreads fixed overheads. **Product and channel mix:** The mix across IQF, fresh, quick-service restaurant (QSR) and value-added products drives realised prices. **Self-supply of inputs:** Internal supply of genetics and feed captures the feed-mill margin and protects biosecurity. The weak points are pricing power and infrastructure: - Broiler selling prices are set by a market where imports supplied about 26% of local consumption in H1 FY2026 [S5]. - Retail promotional intensity also limits pricing. - The business carries high exposure to municipal water and electricity reliability, as shown by the FY2023 loadshedding crisis and the long-running Standerton (Lekwa) dispute [S2][S25]. ### Business and revenue model | Revenue stream | Model | Approximate share | |---|---|---| | Poultry products (IQF, fresh, frozen, value-added, tertiary/offal) | Product sales to retailers, QSR, wholesale and informal trade | Poultry Division: 82.5% of external revenue (FY2025) | | Day-old chicks, hatching eggs, parent stock (Ross 308) | Product sales to external broiler producers; also supplied internally | Within Poultry Division. Breeder revenue grew 24.3% in H1 FY2026; absolute value not disclosed. | | Animal feeds (poultry, layer, pig, dairy, sheep and other livestock) | Product sales. Prices are largely set on a raw-material cost pass-through basis. | Feed Division: 17.5% of external revenue (FY2025) | | Laboratory analytics (Central Analytical Laboratories) | Fee-for-service | Not separately disclosed; immaterial | | Feed delivery service | Delivery fee charged to feed customers | Not separately disclosed. Delivery costs were reclassified into cost of sales in FY2024. | Sources: [S1][S2][S5]. The revenue mix is essentially 100% product sales. There are no subscription or licensing revenues of note. The Ross 308 business is a genetics distribution franchise: Ross is an Aviagen breed, and Astral's Ross Poultry Breeders supplies Ross 308 breeding stock to the South African industry [S38]. ### Value-chain position and cost structure | Ingredient | Share of inclusion | Share of cost | |---|---|---| | Maize | About 59% | About 38% | | Soya meal | About 17% | About 20% | | Extruded soya | About 13% | About 17% | Astral spans every stage from feed raw-material procurement to branded distribution. Its broiler feed formulation in H1 FY2026, presented by the company, breaks down as follows [S5]: Feed cost represented about 66% of the live cost of a broiler in FY2025, about 65% in FY2024 and about 70% in FY2022 [S1][S2][S3]. ### Customer types and end markets | Category | Share of volume | |---|---| | IQF mixed portions | About 49–51% | | Tertiary products | About 21–22% | | Fresh | About 13% | | Value-added | About 7% | | IQF single portions | About 5–6% | | Frozen | About 3% | **Poultry customers:** - National retail chains (promotional frozen and IQF categories) - QSR chains (fresh and QSR cuts, a stated growth channel) - Wholesalers and informal-trade distributors - External broiler producers buying parent stock and day-old chicks **Feed customers:** - Integrated poultry (internal) - External poultry, including commercial layer and table-egg producers - Pig, dairy, sheep and beef producers - Zambian livestock producers, through Tiger Animal Feeds Named customers and customer-concentration percentages are not publicly disclosed [S1][S4][S5]. **Poultry sales mix, H1 FY2026** (approximate, read from the company's chart; total about 261,875 t versus about 259,181 t, volume up about 1%) [S5]:

Revenue$1.3B
Employees11,153
Market Cap$0.4B
Founded2001
Lanseria Ext, South Africa
Aster

Aster DM Healthcare Limited

Premium
Information Technology

| Field | Detail | Source | |---|---|---| | Current legal name | Aster DM Quality Care Limited | Exchange filing, Jul 2026 | | Former names | Aster DM Healthcare Private Limited (2008); Aster DM Healthcare Limited (after conversion to public company; until 3 Jul 2026) | InCred/IIFL company profile; Screener | | Founding of group | 1987, when Dr. Azad Moopen opened a single clinic in Dubai | Bloomberg via Gulf News, Nov 2024 | | Indian incorporation | 18 January 2008, as a private limited company | Company profile (InCred Money) | | Incorporation jurisdiction | India (Companies Act). Merger scheme sanctioned by NCLT Hyderabad Bench | NCLT order coverage, Jan 2026 | | Headquarters / corporate office | Bengaluru, Karnataka (press releases are datelined Bengaluru). | Q4 FY26 and Q1 FY27 press releases | | Exchanges and tickers | NSE: ASTERDM; BSE: 540975 | NSE/BSE filings | | ISIN | INE914M01019 | Exchange data (Bigul) | | CUSIP | Not applicable (no US listing) | — | | Fiscal year end | 31 March | Company filings | | Statutory auditor | Deloitte Haskins & Sells (limited review of Q1 FY27 results) | Q1 FY27 board outcome, 5 Aug 2026 | | Shares outstanding | 871,672,439 equity shares of INR 10 each after merger allotment (up from 518,121,029) | SAST disclosure, Jul 2026 | | Employees (merged entity) | Over 45,000 professionals | Merger completion disclosure, 2 Jul 2026 | | Employees (3-year trend) | Standalone India headcount trend is not publicly disclosed in the sources reviewed. Pre-separation group (incl. GCC) had 34,239 staff | Aster DM Foundation page (GCC-era) | | Market capitalisation | About INR 61,793 crore at INR 708.90 per share on 1 Oct 2026 | IIFL / InCred Money | | Credit ratings | ICRA AA (Stable) / A1+ (Jul 2026); CRISIL AA+ (Stable) / A1+ (Jul 2026) | ICRA and CRISIL rationales | | Website (listed entity IR) | asterdmhealthcare.in (IR); hospital brand sites remain separate | Company IR pages | Aster DM Quality Care is a hospital-led integrated healthcare platform in India. It was formed on 1 July 2026 by merging the founder-led Aster DM Healthcare with Blackstone-controlled Quality Care India. The combined network spans 39 hospitals across 28 cities and more than 10,890 beds under four brands: Aster, CARE Hospitals, KIMSHEALTH and Evercare [Src: Q1 FY27 press release, Aug 2026]. Its footprint is concentrated in South and Central India and Bangladesh, with deliberate exposure to Tier-2 and Tier-3 cities such as Nagpur, Vijayawada and Raipur. Those markets have weaker incumbents and faster growth in insurance and private-hospital demand. On FY26 pro-forma figures, the platform generated INR 9,273 crore of revenue and INR 2,013 crore of operating EBITDA (21.7% margin) [Src: FY26 results, Apr 2026]. That places it in the top three Indian hospital chains by scale. The investment case rests on four things: brownfield-heavy bed additions, merger synergies, clinical depth in quaternary specialties, and joint promoter-PE governance. The main risks are integration execution and a rich valuation. --- ### What the Company Does The company owns and operates multi-specialty and super-specialty hospitals. It also runs clinics, a diagnostics network (Aster Labs and patient experience centres) and digital health channels. Retail pharmacy is run in a franchise-like format: the Aster Pharmacy stores in India are operated by Alfaone Retail Pharmacies Private Limited under a brand licence from Aster [Src: company IR "About Aster DM" page]. Before the merger, Aster DM Healthcare described itself as one of the largest healthcare providers in India. It said it covered primary, secondary, tertiary and quaternary care through 19 hospitals with about 4,867–4,994 beds, 13 clinics, roughly 212–217 brand-licensed pharmacies and 232–243 labs and patient experience centres across five to six states [Src: company IR page, various 2024–25 versions]. By Q3 FY26, standalone Aster reported 20 hospitals [Src: Q3 FY26 press release, Feb 2026]. Labs and PECs reached 321 in Q1 FY27 [Src: AskFuzz aggregation of Q1 FY27 presentation]. ### Business Model and Revenue Model The business is overwhelmingly a service model. Revenue comes from inpatient (IP) and outpatient (OP) hospital services, priced per episode or per day of stay and paid by cash/self-pay patients, private insurers and TPAs, government schemes and international patients. There is no meaningful product, subscription or licensing revenue at group level. The exceptions are: - Brand-licence economics from the Alfaone-operated pharmacies. - Diagnostics revenue from Aster Labs, which is fee-for-service. Key operating drivers disclosed by the company are: - Occupancy: 61% for Aster standalone in FY26; 64% blended pro-forma in Q1 FY27. - Average revenue per occupied bed (ARPOB): INR 51,800 for Aster in FY26. - Average revenue per inpatient (ARPP IP): INR 144,064 for Aster in Q1 FY27, up 9% YoY. - Patient volumes: about 2.01 million pro-forma in Q1 FY27, up 13% YoY. [Src: FY26 results coverage (ScanX); Q1 FY27 press release and transcript summaries.] ### Value-Chain Position and Customers The company sits at the provider end of the healthcare value chain. It buys pharmaceuticals, consumables and equipment from suppliers. It employs or contracts clinicians and bills payers. Customers fall into five groups: - Domestic self-pay patients - Privately insured patients, a growing share of the market - Beneficiaries of government and public-sector schemes - Corporate tie-ups - International "medical value travel" (MVT) patients MVT is material in the Kerala cluster. In Q2 FY26, MVT revenue rose 67% quarter on quarter [Src: FilingReader summary of Q2 FY26 results]. ### Company Self-Description vs. Independent Characterisation **Company language (paraphrased).** Management positions the merged entity as one of India's leading integrated healthcare providers. It cites four trusted brands, a focus on clinical excellence, digitally enabled care and a bias toward high-quality clinical outcomes. It emphasises expanding specialist access to underserved Tier-2 and Tier-3 cities [Src: merger completion releases, Jul 2026]. **Independent characterisation.** In practice the merged entity is a regional-cluster hospital operator with two strong cores: 1. **Kerala.** This is Aster's historic base: Aster Medcity Kochi, Aster MIMS Calicut, Kannur and Kasaragod, and now KIMSHEALTH Thiruvananthapuram. 2. **Telangana / Andhra Pradesh / Central India.** This is the CARE Hospitals footprint plus Aster Ramesh and Aster Prime. The Bengaluru cluster (Aster CMI, Aster RV, Aster Whitefield) and Bangladesh (Evercare) are secondary pillars. Diagnostics and pharmacy are adjacencies, not profit engines. Aster Labs only reached a 12.8% operating EBITDA margin in FY26, up from 7.6% in FY25 [Src: AGM highlights, Oct 2026]. The platform's economic character is mid-ARPOB, volume-led and cluster-dense. It differs from the premium metro-ARPOB model of Max Healthcare (about INR 77,800 ARPOB in FY26) [Src: Upstox peer comparison, 2026].

RevenueN/A
Employees45,000
Market CapN/A
Founded1987
Bengaluru, India
Astec

Astec LifeSciences Limited

Premium
Information Technology

Astec LifeSciences is a small-cap, B2B-only Indian manufacturer of off-patent agrochemical active ingredients (technicals), intermediates and select formulations, and a contract development and manufacturing (CDMO) partner to multinational crop-science and specialty-chemical innovators. Its historical franchise is triazole fungicides — tebuconazole, propiconazole, hexaconazole and related molecules — produced at five plants in MIDC Mahad, Maharashtra. Since Godrej Agrovet took control in 2015, Astec has been repositioned toward higher-value CDMO work and herbicide chemistry, supported by a dedicated R&D centre at Rabale (2023). The 2023–2025 global agrochemical destocking and Chinese generic oversupply hit Astec unusually hard: revenue fell from ₹677 crore (FY22) to ₹381 crore (FY25) and the company has posted three consecutive annual losses. FY26 marked an inflection, with revenue up 17.5%, EBITDA breakeven, and a ₹249 crore rights issue. Its investment case now rests on CDMO ramp-up, operating leverage, and Godrej parentage. --- **Company's own description.** In its recurring "About" boilerplate across FY25–FY27 press releases, Astec describes itself as incorporated in 1994 and engaged in manufacturing agrochemical active ingredients (technical), bulk formulations and intermediate products, with a balanced mix of exports and domestic sales, exporting to over 18 countries (2026 releases; earlier materials cited approximately 24 countries). Its January 2026 PR Newswire release positions it as a manufacturer of agrochemicals, active ingredients and pharmaceutical intermediates with flexible reactor capacities of 3 KL to 32 KL across glass-lined, stainless steel and Hastelloy systems. **What the company does.** Astec runs multi-step organic synthesis in batch reactors to produce (a) technical-grade active ingredients sold to formulators and agrochemical majors (the "Enterprise" business), and (b) custom-synthesised intermediates, active ingredients and specialty chemicals manufactured to customer specifications under contract (the "Contract Manufacturing & New Products" / CDMO business). ICRA's March 2026 rationale summarises the split as technical-grade fungicides and agrochemicals in Enterprise, and agrochemical intermediates and specialty chemicals in CDMO. **Business model and revenue model.** Astec's revenue is almost entirely product revenue from B2B sales; there is no subscription, licensing or royalty income disclosed. Within product revenue, two economic models coexist: *Shares derived from company segment disclosures; company/AR-based summaries report 48% Enterprise / 52% CDMO for FY26.* **Value chain position.** Astec sits in the upstream manufacturing tier of the crop-protection value chain: it buys key starting materials and intermediates (50–55% of raw materials imported, primarily from China, per ICRA), performs synthesis to technical grade, and sells to formulators, distributors and innovators who brand and distribute to farmers. Some backward integration into intermediates partially hedges input cost volatility. It does not operate a farmer-facing branded formulation franchise; that role within the Godrej group sits with Godrej Agrovet's crop protection business, which is also a related-party customer/supplier. **Customer types.** Large agrochemical MNCs (domestic subsidiaries and overseas), Indian formulators, innovator crop-science companies (CDMO), and group companies (GAVL, GIL). Historical disclosures cite Syngenta India and Nufarm as early customers (2009) and custom-synthesis clients in Europe, Japan and the US. Specific current customer names and concentration percentages are not publicly disclosed. **End-markets.** Crop protection (fungicides dominant; herbicides growing; plant-growth regulators), household insecticides (transfluthrin), and life-science/specialty intermediates via CDMO. **Independent characterisation.** Astec is best understood as a sub-scale, single-site specialty chemical manufacturer that was built on a narrow, commoditising triazole portfolio and is now mid-way through a deliberate pivot to CDMO. The pivot is strategically sound — CDMO revenue has greater customer stickiness and pricing insulation — but it is capital-intensive, slow to ramp and lumpy, as evidenced by CDMO revenue swinging from ₹13.6 crore (Q2 FY26, *derived*) to ₹77.6 crore (Q3 FY26) within one quarter. The business carries structurally high working capital (cash conversion cycle of 263 days in FY26 per Screener), leaving it dependent on parent support and short-term debt markets during the downturn.

Revenue$0.1B
Employees528
Market CapN/A
Founded1994
Mumbai, India
ASTA

ASTA Corporation

Premium
Information Technology

ASTA is a small Korean developer and manufacturer of matrix-assisted laser desorption/ionisation time-of-flight (MALDI-TOF) mass spectrometers. It is one of very few companies outside the global incumbents (Bruker, bioMérieux, Shimadzu) and a few Chinese entrants that builds the instrument, sample-preparation consumables and identification databases in-house. Its clinical franchise centres on the MicroIDSys microbial identification system, with a research-stage cancer-diagnostics platform (NosIDSys) alongside. Since 2018 it has repurposed the same time-of-flight core for industrial quality control: LDI-TOF systems for OLED display lines, battery-material analysis, and the GM-TOF real-time gas monitor for semiconductor fabs. Commercial traction remains very limited: revenue has stayed between KRW 2.6bn and 3.4bn for five years, with operating losses every year since listing. The company now depends on new equity, chiefly from SD Biosensor, whose pending takeover and distribution network are the core of any recovery case. That case is constrained by a revenue-recognition audit disclaimer and an unresolved delisting review. --- **What the company does.** ASTA designs, manufactures and sells time-of-flight mass spectrometry systems and related consumables and software. Its founding technology is MALDI-TOF, a technique that ionises biomolecules (typically ribosomal proteins of bacteria and fungi) and identifies an organism by matching its mass "fingerprint" against a reference database. In clinical microbiology this replaces biochemical identification methods that take 8–48 hours with a test of a few minutes. The company's 2019 investor deck claimed identification in under five minutes at about USD 5 per sample, against USD 8–10 for conventional methods [S30]. **Company's own description.** Data-vendor summaries of ASTA's filings describe it as a developer of diagnostic solutions. They list microorganism identification systems (MicroIDSys, MicroIDSys Elite) for rapid infectious-disease diagnosis, food hygiene, agricultural and livestock quarantine and bio-terrorism prevention; the IDSys LT/RT MALDI-TOF platforms; NosIDSys for diagnosis of cancers and degenerative brain diseases; LDI-TOF for OLED analysis; disposable MALDI plates; a rapid enzyme digestion system; and diagnostic software [S37]. A July 2025 KOSDAQ technology analysis report describes ASTA as a developer of next-generation diagnostic and QC platforms built on proprietary MALDI-TOF technology. That report lists industrial products (LDI-TOF, GM-TOF, IDSys Premier) supplied to LG Display and others, and a Saudi joint venture (ASTA LLC) under Saudi Vision 2030 [S36]. **Business model.** The model is mainly a hardware-plus-consumables model: **Instrument sales:** capital equipment sold to hospitals, research institutes, distributors and industrial customers. **Consumables:** disposable MALDI plates (μFOCUS), sample-preparation kits (SepsiPrep, blood kits), magnetic beads and reagents. **Software and databases:** microbial and cancer reference databases and AI and cloud diagnostic software. The company has promoted a cloud-connected MALDI-TOF platform linking instruments to a central data centre for remote diagnosis and disease surveillance [S25]. **Government R&D grants:** the company leads a KRW 4bn national display-process R&D project (2024) [S27]. ASTA does not publish a product/service/subscription/licensing revenue split. A 2011 licence-in of cancer-diagnostic technology from US firm Glycometrix is the only licensing arrangement identified [S30]. No subscription or recurring-software revenue has been disclosed. **Value-chain position.** ASTA is vertically integrated across instrument design, core components, consumables and database development. The company has claimed it is the only firm that makes the analyser, its parts and its consumables in-house [S29]. Downstream it relies on distributors, both overseas (most sales, per a July 2025 company statement [S22]) and domestic hospital channels. The pending SD Biosensor transaction is meant to add a global distribution layer through SD Biosensor's overseas subsidiaries in nine countries [S8]. **Customer types and end-markets.** **Independent characterisation.** ASTA is a technology-rich, commercially sub-scale company. It has spent nearly two decades building a credible MALDI-TOF capability, yet annual revenue has never exceeded KRW 3.4bn, and in FY2025 payroll alone (KRW 2.47bn) was 95.3% of revenue [S2]. Clinical microbiology is a high-barrier, incumbent-dominated market. Hospitals there buy on installed base and database breadth, and the Korean domestic market has historically preferred foreign products [S28]. The industrial QC pivot is technically interesting but has produced only "small but steady" annual shipments to large domestic firms [S26]. The financial history is defined by recurring equity raises, repeated going-concern pressure (capital impairment, revenue-threshold risk), and serious governance questions over related-party dealings. Those questions culminated in the FY2025 audit disclaimer over the substance and timing of certain FY2024–FY2025 sales [S9].

Revenue$0.0B
Employees38
Market CapN/A
Founded2006
Suwon, South Korea
Associated

Associated Alcohols & Breweries Limited

Premium
Information Technology

### Core Identification | Field | Detail | |---|---| | Legal name | Associated Alcohols & Breweries Limited | | Entity profiled | Same listed entity as the identification list. No name change or listing migration was found. Profiled entity: Associated Alcohols & Breweries Ltd, India, NSE: ASALCBR / BSE: 507526, website associatedalcohols.com | | Former names | None identified in public filings reviewed | | Group | Flagship company of the Indore-based Associated Kedia Group, promoted by the late Bhagwati Prasad Kedia (CRISIL rationale, 30 Oct 2025) | | Founding / incorporation | 1989 (CIN L15520MP1989PLC049380; CRISIL; company press release July 2026) | | Incorporation jurisdiction | Madhya Pradesh, India (Registrar of Companies, MP; "MP" in the CIN) | | Registered and corporate office | 4th Floor, BPK Star Tower, A.B. Road, Indore 452008, Madhya Pradesh | | Principal plant | Khodigram, Tehsil Barwaha, District Khargone 451115, Madhya Pradesh | | Exchanges and tickers | NSE: ASALCBR; BSE: 507526; Reuters: ASAL.NS | | ISIN | INE073G01016 | | CUSIP | Not applicable (no US listing) | | Face value | INR 10 per share | | Shares outstanding (derived) | About 2.008 Cr shares. Base of 1.808 Cr (paid-up capital INR 18.08 Cr), plus 9,00,000 warrant shares (Sept 2025), plus 11,00,000 warrant shares (Mar 2026). Cross-check: market cap ÷ price gives the same count | | Fiscal year end | 31 March | | Employees | 547 full-time (Alphaspread/data-vendor profile; reference year not stated). A 3-year headcount trend is not publicly disclosed in sources reviewed | | Employee cost (proxy for scale) | FY22 INR 31.6 Cr; FY23 35.3 Cr; FY24 36.8 Cr; FY25 46.5 Cr (C-MOTS data via Muthoot Securities) | | Statutory auditor | Singhi & Co., Chartered Accountants (signed FY24 audit report and Q1 FY24 review). The FY26 auditor was not re-verified; the FY26 Annual Report is the reference | | Market capitalisation | About INR 1,167.5 Cr at INR 581.4 per share (Kotak Neo/Screener, 19–20 Oct 2026) | | 52-week range | INR 1,277 high / INR 567 low (as of 19 Oct 2026) | | Credit rating | CRISIL A-/Positive (long term); CRISIL A2+ (short term). Outlook revised to Positive on 30 Oct 2025 | | Website | www.associatedalcohols.com | | Investor relations agency | Go India Advisors | | Company Secretary | Abhinav Mathur (Company Secretary & Compliance Officer) | ### Market Capitalisation Trajectory (selected data points) | Date | Share price (INR) | Market cap (INR Cr) | Source | |---|---|---|---| | 20 Apr 2026 | 884.7 | Not stated | Kotak Neo | | 22 Jul 2026 | 784.3 | Not stated | Kotak Neo | | 24 Jul 2026 | 821.45 | Not stated | Univest | | 19 Oct 2026 | 581.4 | 1,167.5 | Kotak Neo / Screener | Associated Alcohols & Breweries is a vertically integrated, mid-sized Indian alcoholic-beverage manufacturer. It has historically been anchored in Madhya Pradesh. From a single 150-acre location at Khargone, it operates: - grain-based distillation for extra-neutral alcohol (ENA) and fuel ethanol - 41 bottling lines - captive power - a newly commissioned malt plant The company has three strands of business: - a quota-protected country-liquor (IMIL) franchise in nine MP districts - contract and licensed bottling for multinational brand owners - a fast-growing proprietary IMFL portfolio led by the Central Province (CP) series, Nicobar Gin and Hillfort whisky Management is repositioning AABL from a commodity-and-contract distiller into a branded, pan-India spirits house. The stated targets are: - proprietary IMFL at about 50% of revenue excluding ethanol by FY30 - tequila, RTD and single-malt extensions The investment case is a two-speed business: - a high-margin brand engine growing 30–58% - an ethanol and ENA arm exposed to grain prices and government allocation ### Commentary AABL is a small-cap with a strong balance sheet: - standalone net worth of about INR 695 Cr at FY26 - net cash position (net debt/equity of –0.09x per the FY26 investor deck) It now trades at about 14x trailing earnings. That is a steep discount to listed premium-spirits peers. The de-rating reflects three things: - earnings volatility from ethanol - a regulatory overhang: the CCI cartel probe and an FSSAI labelling action - the slow scale-up of premium launches --- ### What the Company Does AABL manufactures and sells potable alcohol across the full value chain: 1. Grain procurement (mainly maize and broken or FCI rice) 2. Distillation into rectified spirit and ENA 3. Blending and maturation, including malt spirit since FY26 4. Bottling 5. Sale to state excise corporations, depots or distributors, depending on each state's regime The company also runs a dedicated grain-based fuel-ethanol plant. It sells ethanol to oil marketing companies (OMCs) under the central Ethanol Blended Petrol (EBP) programme and, since FY26, to private OMCs. Distillery by-products such as cattle feed (DDGS) are sold (FY26 investor deck, as summarised by Multibagg). ### Company's Own Description The Annual Report describes the business as manufacturing and trading of: - ENA - Indian Made Indian Liquor (country liquor) - Indian Made Foreign Liquor - hand sanitiser This is per the Annual Report 2020, page 88, the description used by Screener. The July 2026 company press release describes AABL as an Indian spirits and distillery company established in 1989. It says the company focuses on manufacturing capability, proprietary brands, market expansion and sustainable growth. ### Revenue Model and Business Lines (management reporting) | Business line | Model | Customer | FY26 revenue (INR Cr) | FY26 share of revenue | |---|---|---|---|---| | IMFL – Proprietary | Own brands; product sale | State corporations / distributors / retail (state-dependent) | 177.0 | 17% | | IMFL – Licensed / franchise | Manufacture and sale of brand-owner brands under licence (franchise) | Brand owner's route to market | 152.2 | 20% (as presented) | | IMIL (country liquor) | Quota-based supply under MP excise tender | Government of MP / district retail | 255.9 | about 25% (derived) | | Merchant ENA | Bulk spirit sale | Other bottlers and IMFL companies | 146.9 | 14% | | Ethanol | Bulk fuel-ethanol sale | Public-sector OMCs (annual tender allocation) and private OMCs | 201.9 | 15% as presented (conflict: 201.9 ÷ 1,019.4 = 19.8%) | | Contract manufacturing / job work and by-products | Toll/job-work fees; DDGS/cattle feed | Brand owners (e.g. Diageo, Inbrew); feed buyers | Balance, about 85 (derived) | about 8% (derived) | | Total net revenue from operations | — | — | 1,019.4 | 100% | Source: FY26 investor deck and Q4 FY26 call, as summarised by Multibagg (20 May 2026). The IMIL share and the "Other" line are derived by subtraction. ### Revenue Mix by Model | Model | Approximate FY26 share | Comment | |---|---|---| | Product sale (own brands: proprietary IMFL + IMIL) | about 42% | Highest-margin pool; IMIL capped by quota | | Bulk commodity sale (ENA + ethanol) | about 29–34% | Grain- and policy-exposed | | Licensing / franchise manufacturing | about 15–20% | Declining structurally after the Inbrew conversion and the end of the USL franchise | | Services (job work) | Small; not separately disclosed | Grows as licensed volumes convert to job work | | Subscription / IP licensing out | 0% | Not applicable | ### Value-Chain Position AABL is unusually integrated for its size: - captive ENA meets 100% of internal needs (captive share of ENA output was 59% in Q1 FY27 versus 50% in FY26, per the Q1 FY27 call) - captive steam and power from the ethanol plant's boiler, plus a 10.5 MW captive power unit described as a "net energy surplus unit" (Go India conference deck, Jan 2026) - in-house malt spirit from FY28 for blends and single malt Downstream, route-to-market is dictated by state excise regimes. In MP, country liquor is supplied to the state under district quotas. In Kerala, sales go through the state beverages corporation; AABL ranks among the top 5 IMFL suppliers there (company presentation cited by Screener). Elsewhere, sales go through distributors and depots. ### End-Markets and Customers The company serves four groups of customers: - Indian consumers of mass, regular and prestige spirits (IMIL, IMFL) - other spirit makers (merchant ENA) - the national fuel-blending programme (ethanol) - multinational brand owners, historically Diageo/United Spirits and Inbrew (contract and licensed bottling) ### Independent Characterisation AABL is best understood as three businesses inside one plant: 1. **A regulated, cash-generative IMIL utility in MP.** Volume is about 4–4.7 million cases a year at about 0.98–1.17 million cases a quarter. It is capped by quota, and management says it already receives the maximum quota available. 2. **A commodity distillery.** This covers ENA and ethanol, totalling about 70 million litres a year of output. Its returns swing with maize and rice prices and with OMC allocation. Ethanol made an operating loss of INR 4.7 Cr in Q1 FY27. 3. **An emerging brand company.** Proprietary IMFL is about 2.4 million cases in FY26, growing 30–40% in volume, with 18–22% segment EBITDA margins. The equity story depends almost entirely on the third business scaling fast enough to dilute the volatility of the second.

Revenue$0.0B
Employees547
Market CapN/A
Founded1989
Indore, India
Assam

Assam Entrade Limited

Premium
Information Technology

Assam Entrade Limited is a four-decade-old, family-controlled, Kanpur-run micro-cap non-banking financial company whose economic substance is a Rs 64 Cr equity base deployed mainly into inter-corporate loans, with smaller books of unlisted equity investments, traded securities and mutual-fund units. It does not take public deposits, carries almost no leverage, employs fewer than ten people and pays no dividend. Its loan book is highly concentrated, including a shareholder-approved related-party lending limit of up to Rs 60 Cr with Mantora Oil Products Pvt Ltd, a Kanpur edible-oil refiner. The company's emerging strategic optionality is real estate: it is lead member of a corporate consortium developing a 66.68-acre integrated township in Kanpur that received Kanpur Development Authority final layout approval in February 2026. The listed equity is extremely illiquid, trades at roughly 1.8x book and 60x earnings, and is best characterised as a closely held balance sheet with a speculative real-estate option attached. --- ### Company's own description In its FY2025 Directors' Report (40th Annual Report), the company describes itself as engaged in trading in shares and securities, providing inter-corporate loans and trading in mutual fund units, operating as an NBFC that does not accept public deposits, under a certificate of registration from the RBI's Department of Non-Banking Supervision. The FY2024 report uses the same characterisation. Exchange-sourced summaries (IIFL, MarketScreener) add that the company's objects also include real estate activities, construction of residential and commercial accommodation and acting as a real estate agent, and that it is the lead member of a consortium developing an integrated residential township. ### Independent characterisation Functionally, Assam Entrade is a promoter-run investment and lending vehicle rather than an operating lender in the retail or MSME sense. Three observations define the business: 1. **Lending is wholesale, concentrated and relationship-based.** Loans constituted 67.38% of total assets at 31 March 2024 according to the statutory auditor's emphasis paragraph (FY2024), i.e. roughly Rs 40 Cr against total assets of Rs 60.07 Cr. In FY2024 shareholders approved, by special resolution, material related-party transactions with Mantora Oil Products Pvt Ltd of up to Rs 60 Cr under a loan agreement. Screener's AI-extracted insights track a "single-borrower concentration (Mantora Oil Products)" metric, though the value is behind a paywall. The economic profile is therefore closer to a captive treasury for a related business group than to a diversified lender. 2. **Investment and treasury income drive reported profits.** In FY2025 and FY2026, "other income" (Rs 4.26 Cr and Rs 4.64 Cr respectively) exceeded profit before tax (Rs 4.07 Cr and Rs 3.06 Cr). Core operating profit before other income turned negative in both years. Composition of other income (gains on investments, fair-value changes, dividends) is not itemised in the sources reviewed. 3. **Real estate is a nascent second leg.** Capital work-in-progress rose from Rs 1.33 Cr (FY2024) to Rs 5.63 Cr (FY2025) and Rs 5.84 Cr (FY2026). In an August 2026 board update, the company reported that its 66.68-acre Integrated Township Project in Kanpur holds a development licence, a KDA-approved detailed project report and final layout approval (February 2026), and that it leads a consortium of corporates. No construction, sales, funding plan or timeline has been disclosed. Linking the CWIP build-up to the township is an analytical inference, not a disclosed fact. ### Revenue model | Revenue type | Description | Disclosure status | |---|---|---| | Interest income on inter-corporate loans | Core recurring revenue; loans to body corporates and individuals | Amount not itemised in sources reviewed; Screener AI tracks "Interest Income on Loans" (paywalled) | | Sale of shares and securities (trading income) | Proceeds or net gains from trading stock-in-trade | Amount not itemised in sources reviewed | | Mutual fund units trading | Treasury deployment | Not itemised | | Other income | Includes investment gains; drove FY2025–FY2026 profits | FY2025 Rs 426.45 lakh (Directors' Report) | | Real estate / township | Pre-revenue | No revenue recognised to date | Mix: by structure, the company is ~100% financial-services income with no product, subscription or licensing revenue. A precise split between interest and trading income is not publicly disclosed. ### Value chain, customers and end-markets **Value chain position:** Capital provider (balance-sheet lender/investor); prospective land/township developer. **Customer types:** Body corporates, individuals and other entities (IIFL summary); in practice, a small number of corporate borrowers including at least one related party. **End-markets:** Indian wholesale inter-corporate credit; Indian listed/unlisted equities and mutual funds; Kanpur (Uttar Pradesh) residential real estate. **Geography:** India only; no foreign exchange earnings or outgo in FY2024 and FY2025 (Directors' Reports).

Revenue$0.0B
Employees5
Market CapN/A
Founded1985
Kolkata, India
Aspira

Aspira Pathlab & Diagnostics Limited

Premium
Information Technology

| Field | Detail | |---|---| | Entity profiled | Aspira Pathlab & Diagnostics Limited (same entity as the one on the input list; no relisting or merger) | | Legal name | Aspira Pathlab & Diagnostics Limited | | Former name | Utkal Soap Products Limited (name changed 16 November 2016) | | Date of incorporation | 3 July 1973 | | Original state of registration | West Bengal (registered office moved to Maharashtra by order dated 18 November 2016) | | Corporate Identification Number (CIN) | L85100MH1973PLC289209 | | Registrar of Companies | RoC Mumbai | | Registered office | Flat No. 2, R D Shah Building, Shraddhanand Road, Opp. Railway Station, Ghatkopar (West), Mumbai 400 086, Maharashtra, India | | Corporate office (as disclosed in 2019 filings) | Plot No. 6, RPT House, Sector 24, Turbhe, Navi Mumbai 400 703 (current status not re-verified) | | Primary listing | BSE Limited. Scrip code 540788; Security ID ASPIRA | | Other tickers | Yahoo: ASPIRA.BO; Reuters: ASPR.BO; some broker sites show NSE symbol "ASPIRA" | | Historical listings | Calcutta Stock Exchange and Metropolitan Stock Exchange of India (both delisted) | | ISIN | INE500C01017 | | CUSIP | Not applicable (Indian security) | | Face value | ₹10 per share | | Shares outstanding | 1,02,93,000 equity shares (10.293 million). Equity share capital ₹10.29 Cr per the open-offer filing. One company-registry aggregator shows paid-up capital of ₹15.79 Cr against authorised capital of ₹35.00 Cr. This discrepancy is unreconciled and could reflect a post-June-2026 allotment or an aggregator error. | | Fiscal year end | 31 March | | Statutory auditor | refer to the FY2025-26 Annual Report | | Registrar and Transfer Agent | Link Intime (India) Pvt Ltd per FY2021-22 Annual Report (previously Sharex Dynamic (India) Pvt Ltd in FY2018-19) | | Banker (FY2021-22 AR) | Bank of Baroda | | Website | www.aspiradiagnostics.com | | Brand taglines | "Predict • Prevent • Protect"; "India's First Fully Integrated Lab" (company letterhead) | | Metric | FY2024 | FY2025 | FY2026 | |---|---|---|---| | Employees (count) | NA | NA | 141 | The 141 figure is PitchBook's profile count as of 2026. ### Market Value (Latest) | Metric | Value | |---|---| | Closing share price (BSE, 19 Oct 2026) | ₹114.95 | | Market capitalisation (derived: ₹114.95 × 1.0293 Cr shares) | approx. ₹118 Cr (approx. USD 14 million) | | 52-week high / low (as of mid-2026) | ₹135.88 / ₹49.00 | | Promoter holding (June 2026) | 46.58% | Aspira Pathlab & Diagnostics is a Mumbai-based micro-cap pathology and radiology services company. It operates through a shell-company route: a 1973 West Bengal soap manufacturer, Utkal Soap Products, was repurposed in 2016 by acquiring the running business of Ankur Pathology Laboratory. The company runs diagnostic centres concentrated in Mumbai, chiefly Ghatkopar and the eastern suburbs. Its services span pathology (biochemistry, haematology, histopathology, microbiology, immunology, virology, cytology), radiology (X-ray, ultrasound), and cardiology investigations. It serves walk-in and home-collection patients (B2C), plus hospitals, laboratories and corporates (B2B), including a growing Hospital Lab Management (HLM) offer. With FY2026 revenue of ₹24.98 Cr and near-breakeven profit, Aspira is a sub-scale regional player in a market dominated by national chains such as Dr Lal PathLabs and Metropolis. In 2026 its ownership was reshaped by a ₹55-per-share SEBI open offer that consolidated control with the Bhanushali–Mange family group. The company is now planning a rights issue of up to ₹65 Cr. --- ### What the Company Does Aspira's exchange-filed description says it is engaged in running, owning, managing and administering diagnostic centres. Its principal activities are pathology investigation services, radiology investigation services and related healthcare services at diagnostic centres in Mumbai. Its corporate profile describes it as a pathology specialist serving individual patients, hospitals, other healthcare providers and businesses. The profile says the company is built on technological automation, a patient-centric approach and dependable results. It also states an intention to establish itself as a strong regional player before scaling up. The company claims a "pan-India presence" in some profile text, but the operating disclosures point to a Mumbai and Maharashtra concentration. We treat the regional description as the accurate one. ### Business Model The company operates a classic hub-and-spoke diagnostics model: **Hub (processing laboratory):** a central lab in Mumbai where samples are processed on automated analysers. Company materials emphasise IT integration to cut human error and track samples. **Spokes (collection network):** owned diagnostic centres, franchise or partner collection points, and home sample collection. One data provider states the company operates "over 600 centres" and added 91 locations in FY2024-25. These are almost certainly collection or touch points rather than full-service laboratories. **B2B channel:** referral testing for hospitals, nursing homes, clinics and smaller laboratories, plus Hospital Lab Management (HLM). Under HLM, Aspira runs in-house laboratories for hospitals. Management commentary says it is targeting newly set-up hospitals and laboratories. **Digital initiatives:** cited by management: a chatbot, website upgrades, a patient-engagement platform and customer-service improvements. ### Revenue Model | Revenue type | Description | Disclosed share | |---|---|---| | Fee-for-service testing (B2C) | Per-test or per-package fees from walk-in and home-collection patients | Not publicly disclosed | | B2B referral testing | Per-test fees billed to hospitals, clinics and labs, usually at discounted B2B rates | Not publicly disclosed | | Hospital Lab Management (HLM) | Service contracts to run hospital laboratories; may include revenue share or fixed fees | Not publicly disclosed | | Corporate and preventive health | Wellness packages for employers and individuals | Not publicly disclosed | | Product, subscription, licensing | None identified | 0% | All revenue is service revenue. There is no product, subscription or licensing income. ### Value Chain Position Aspira sits at the service-delivery end of the diagnostics value chain. Upstream are in-vitro diagnostic (IVD) equipment and reagent suppliers, typically multinationals such as Roche, Abbott, Siemens Healthineers, Beckman Coulter and Sysmex. Downstream are referring doctors, hospitals and patients. With about ₹25 Cr of revenue, Aspira has limited bargaining power against reagent suppliers. It competes for doctor referrals against chains that are 50 to 100 times its size. ### Customer Types and End-Markets | Customer type | Notes | |---|---| | Individual patients | Walk-in and home collection in Mumbai suburbs | | Referring physicians | The traditional standalone-lab referral model in Mumbai | | Hospitals and nursing homes | B2B referral plus HLM | | Other laboratories | Outsourced specialised tests | | Corporates and businesses | Pre-employment and wellness testing | The end-market is the Indian diagnostics services market, specifically the Mumbai Metropolitan Region. ### Independent Characterisation Aspira is best described as a single-city, single-segment, sub-scale diagnostics operator with a listed-shell history. Its economics are highly sensitive to volume. Depreciation, much of it on right-of-use lease assets, runs at about ₹1.5 Cr per year against about ₹25 Cr of revenue. Small revenue swings therefore move it between double-digit operating margins and losses. This is visible in FY2024 (loss), FY2025 (profit) and FY2026 (breakeven). The FY2022 peak profit reflected COVID-era testing demand. The company's strategic future is now tied to the newly consolidated promoter group and the use of the proposed ₹65 Cr rights issue. That sum is more than 2.5 times annual revenue and about half the current market capitalisation.

Revenue$0.0B
Employees141
Market Cap$0.0B
Founded1973
Mumbai, India
Aspinwall

Aspinwall and Company Limited

Premium
Information Technology

Aspinwall and Company is one of the oldest surviving commercial houses on India's Malabar Coast. It is a 159-year-old, family-controlled, diversified micro-cap run by members of the erstwhile Royal Family of Travancore, who have held control since the early 1970s. The company operates four modest but distinct businesses. The first is port-centric logistics and customs brokerage across southern and western India. The second is the procurement, curing and export of specialty Indian coffees, notably Monsooned Malabar, mainly to European roasters. The third is a natural-rubber estate of roughly 2,200 acres in Malappuram, Kerala. The fourth is a small coir and natural-fibre manufacturing operation. Revenue reached INR 417 crore in FY2026, up 24% year on year. Margins, however, are thin and volatile: operating margin has stayed in a 3–8% band for five years, and net margin was about 3%. The investment case therefore rests less on growth than on three things: a conservative balance sheet, an unbroken dividend record, and a share price below book value. --- ### The company's own description The FY2025-26 Directors' Report describes Aspinwall as a diversified business entity. It names five activities: logistics services, coffee processing and trading, rubber plantations, and the manufacture and trading of natural fibre products and mattresses. Screener's summary of the FY2026 Annual Report adds commercial real-estate leasing of the company's "Aspinwall House" premises as a further activity. The Directors' Report says the company is working to use its facilities more fully to raise revenue from them. Morningstar's profile, drawn from filings, states that the reportable segments are Logistics, Coffee, Plantation and Others. ### Independent characterization Aspinwall is best understood as a working-capital-intensive agri-commodity exporter combined with an asset-light trade-services business, held together by a family holding structure. It is not a single integrated value chain. The two main businesses, Coffee and Logistics, produced about 81% of FY2026 revenue (CRISIL describes the pair as "nearly 80%"). They have different economics: **Coffee:** is a merchant-processor model. Aspinwall buys green coffee, mainly from Karnataka and Kerala growers and traders. It then cures, grades, "monsoons" and exports it. Profit is a processing-and-trading spread, and it is exposed to two things: ICE coffee futures and domestic procurement prices. Profitability also depends heavily on inventory, because CRISIL notes a processing and sales cycle of 6–9 months. **Logistics:** is a fee-based service model. The company acts as customs house agent, liner and ship agent, handles bulk cargo, provides stevedoring, freight forwarding, air cargo (IATA-accredited), warehousing, and project or over-dimensional cargo handling. Margins are steady at about 8–10% of segment revenue. Volumes follow India's EXIM trade cycle and port-specific bulk flows, particularly at Mangaluru. **Plantation:** is a natural-rubber estate. It produces centrifuged latex and technically specified natural rubber, and also makes Esophageal Varices Ligation (EVL) bands, a medical consumable. Earnings follow rubber prices and the age profile of the trees. **Others:** consists mainly of natural fibre (coir mats, mattings, rugs, runners, mattresses and coir geotextiles through a subsidiary), healthcare products and minor trading. This segment has been at or below breakeven for most of the last five years. ### Revenue model mix | Revenue type | Businesses | Approximate share of FY2026 revenue | Basis | |---|---|---|---| | Product sales (commodity and manufactured goods) | Coffee, Plantation (rubber, latex, EVL bands), Natural fibre, Healthcare | About 62% | Zonebourse segment data: Coffee + Plantation + Others = INR 256.7 crore out of 416.7 crore | | Service fees | Logistics (CHA, freight forwarding, ship agency, stevedoring, warehousing), pharma logistics (SFS) | About 38% | Logistics segment INR 160 crore | | Rental/leasing | Aspinwall House premises | Not separately disclosed (immaterial; included in other income or Others) | Directors' Report FY2026 mentions leasing optimisation | | Subscription/licensing | None | 0% | — | ### Value-chain position, customers and end-markets | Business | Value-chain position | Customer types | End-markets | |---|---|---|---| | Coffee | Mid-stream: procurement, curing, monsooning, grading, export | Specialty and commercial roasters, green-coffee importers | Exports, about 85% to Switzerland, Germany, Italy, the UK and Scandinavia; the balance to Australia, the USA, Japan and Russia (company disclosure cited by TradingView research); plus domestic sales | | Logistics | Intermediary service provider at ports, ICDs and airports | Exporters, importers, shipping lines, project cargo owners, pharma and clinical-trial sponsors (via SFS Pharma Logistics) | Indian EXIM trade, bulk commodities, project cargo | | Plantation | Upstream grower and primary processor | Tyre and rubber-goods manufacturers, latex users, hospitals and distributors (EVL bands) | Domestic natural-rubber market; medical devices | | Natural fibre | Manufacturer and exporter | Retailers and importers of floor coverings; domestic mattress buyers; infrastructure and erosion-control buyers (geotextiles) | The USA, Europe and India |

Revenue$0.0B
Employees711
Market CapN/A
Founded1867
Logistics, India
Aspen

Aspen Pharmacare Holdings Limited

Premium
Information Technology

FY2023 is from the sustainability supplement. FY2025 is from the Profile's Handbook (2025 Issue 2). FY2024 and post-divestment FY2026 headcounts were not captured. Third-party data aggregators show 8,867 and 9,557, and these are not reconcilable. Aspen Pharmacare is Africa's largest pharmaceutical company. It is a JSE-listed specialty and branded multinational, run by its co-founder and Group CEO Stephen Saad. It operates through two segments. Commercial Pharmaceuticals (about 73% of FY2026 continuing revenue) markets post-patent branded prescription, OTC and hospital injectable medicines in emerging and developed markets. Manufacturing (about 27%) runs sterile finished-dose (FDF), oral and API plants in South Africa, France and the Netherlands, among other sites, and serves both internal and third-party contracts. FY2026 was a reset year. The R28bn sale of APAC to BGH Capital moved the group from about R31bn of net debt to net cash. Restructuring of the sterile plants in France and South Africa repaired Manufacturing profitability after an mRNA contract was lost. Mounjaro in South Africa became the main growth driver in Commercial Pharma. The investment case now depends on GLP-1s (in-licensed tirzepatide marketing and its own generic semaglutide), sterile capacity fill (insulin, vaccines, GLP-1) and capital returns. --- ### Company's own description Aspen describes itself as a global specialty and branded pharmaceutical company. It says it improves patient health through high-quality, affordable medicines, is active at every stage of the value chain, and is diversified by geography, product and manufacturing capability (aspenpharma.com investor hub). Its stated strategy has three parts: build product portfolios that achieve organic growth, build a differentiated portfolio of relevant IP, and use complex manufacturing capability plus a globally integrated supply chain to create value and enable access to medicines (investor hub, 2026). Its purpose statement is to improve the health and quality of life of patients. The corporate credo is "Healthcare. We Care." ### Independent characterisation In practice Aspen has three economic engines. 1. **A brand-acquisition and in-licensing commercial platform (Commercial Pharmaceuticals).** Since 1997 Aspen has bought mature, off-patent or non-core brands from multinationals, including GSK, AstraZeneca, MSD, Viatris and Sandoz. It markets them through its own affiliates, mainly in emerging markets: Sub-Saharan Africa, the Middle East, Latin America and China. It increasingly also distributes innovator products in South Africa and Sub-Saharan Africa under long-term agreements with Eli Lilly and Boehringer Ingelheim. Revenue is product sales, priced under regulated systems such as South Africa's Single Exit Price and China's volume-based procurement (VBP). There is no material subscription or licensing-fee income. 2. **A multi-site manufacturing business (Manufacturing).** This makes FDF products (sterile injectables, oral solids, liquids, semi-solids) and APIs, including hormones and specialised chemistry at Oss (Netherlands) and Fine Chemicals Corporation (Cape Town), plus heparin, now on a working-capital-light toll model. Revenue comes from contract manufacturing (CMO/CDMO) for third parties, internal supply and API sales. This segment carries Aspen's largest fixed-cost and execution risk, which became visible when the mRNA contract was lost in FY2025. 3. **An emerging GLP-1 and specialty access franchise.** Aspen distributes Lilly's Mounjaro in South Africa and Sub-Saharan Africa and holds licensed IP for generic semaglutide, approved in Canada in July 2026. It has also secured access licences such as MSD's alimatravir for HIV prevention (July 2026) and Serum Institute paediatric vaccines (2022). ### Revenue model mix (FY2025, total operations) | Revenue type | FY2025 ZAR M | Share of group (%) | Basis | |---|---|---|---| | Branded product sales – Prescription | 12519 | 28.9 | FY2025 segmental analysis | | Branded product sales – OTC | 9812 | 22.6 | FY2025 segmental analysis | | Branded product sales – Injectables | 9885 | 22.8 | FY2025 segmental analysis | | Manufacturing – FDF (third-party and contract) | 5099 | 11.8 | FY2025 revenue analysis | | Manufacturing – API | 4718 | 10.9 | FY2025 revenue analysis | | Manufacturing – Heparin | 1330 | 3.1 | FY2025 revenue analysis | | Total | 43363 | 100.0 | — | Subscription and licensing-fee revenue is not separately disclosed and appears immaterial. ### Value-chain position, customers and end-markets **Value chain:** Aspen covers API synthesis, FDF manufacture (sterile and non-sterile), regulatory registration, marketing and distribution. Upstream discovery R&D is limited; the group relies on in-licensing and acquired IP. **Customer types:** - Public-sector tender buyers, such as South African state ARV and insulin tenders and China's VBP. - Private wholesalers and pharmacies (OTC and prescription). - Hospitals (anaesthetics and injectables). - Multinational pharma contract customers (FDF and API toll and contract manufacturing). - Multilateral buyers for vaccines (the target for the Serum Institute and Africa CDC frameworks). **End-markets:** anaesthesia, thrombosis, oncology (legacy cytotoxics), metabolic/diabetes and obesity (Mounjaro, semaglutide, insulin), pain and central nervous system (Lyrica, Celebrex in Latin America), consumer health and OTC, infectious disease (HIV, vaccines) and hormones (API).

Revenue$1.9B
Employees9,161
Market CapN/A
Founded1997
Durban, South Africa

Page 84 of 482

1…838485…482

Page 84 of 482

Go to page
Deloitte logo
Accenture logo
Oracle logo
PWC logo
EY logo
Honeywell logo